chr9:21967751:> Detail (hg19) (CDKN2A)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr9:21,967,751-21,995,300 |
hg38 | chr9:21,967,752-21,995,301 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
pancreatic cancer | Palbociclib | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 4 | Detail | |
cholangiocarcinoma | Palbociclib | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 4 | Detail |
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.144 | squamous cell carcinoma | The p14 promoter was unmethylated in 86.7 % of OSCC and in 85.7 % of LSCC patien... | BeFree,GAD,LHGDN | 24710824 | Detail |
0.144 | squamous cell carcinoma | The correlation between p16 expression and INK4a locus mutation with grades and ... | BeFree,GAD,LHGDN | 24739827 | Detail |
0.144 | squamous cell carcinoma | HPV infection appears to be involved in cancer progression in SQC by promoting t... | BeFree,GAD,LHGDN | 25544708 | Detail |
0.144 | squamous cell carcinoma | p16INK4A expression in squamous cell carcinomas of the vagina and the vulva in T... | BeFree,GAD,LHGDN | 25605180 | Detail |
0.144 | squamous cell carcinoma | Development of squamous cell cancer of head and neck (SCCHN) is associated with ... | BeFree,GAD,LHGDN | 25640361 | Detail |
0.144 | squamous cell carcinoma | Human papillomavirus (HPV), p16 expression, and TP53 mutations are known prognos... | BeFree,GAD,LHGDN | 25871546 | Detail |
0.144 | squamous cell carcinoma | These findings utilize morphologic and immunohistochemical analysis to support H... | BeFree,GAD,LHGDN | 26171917 | Detail |
0.008 | Carcinoma, Transitional Cell | To determine the potential association between HPV infection and the squamous ce... | BeFree,LHGDN | 24675970 | Detail |
<0.001 | carcinosarcoma | NA | BeFree | Detail | |
<0.001 | Cardiomyopathy, Dilated | Transcriptome analysis of mouse and human DCM samples indicates that p16(INK4a) ... | BeFree | 25751743 | Detail |
<0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
<0.001 | celiac disease | A dense infiltrate of IL-6(+) mononuclear cells was detected in active coeliac d... | BeFree | 25198673 | Detail |
0.007 | intracranial aneurysm | NA | BeFree,GAD | Detail | |
0.005 | brain ischemia | NA | GAD | Detail | |
0.014 | Malignant tumor of cervix | Medline, Embase and China National Knowledge Infrastructures were searched to id... | BeFree | 25461355 | Detail |
0.014 | Malignant tumor of cervix | Methylation of the p16(INK4a) gene occurs early in the development of cervical c... | BeFree | 25579180 | Detail |
0.014 | Malignant tumor of cervix | p16INK4A expression could be used as a useful marker for HPV positivity in vagin... | BeFree | 25605180 | Detail |
0.014 | Malignant tumor of cervix | Moreover, p16 protein was associated with CIN grade and lymph node metastases in... | BeFree | 25910412 | Detail |
<0.001 | cervical polyp | NA | BeFree | Detail | |
<0.001 | Uterine Cervicitis | Immunohistochemistry of p16INK4A staining shows nil (0/25) expression in the cer... | BeFree | 25361681 | Detail |
<0.001 | Cervix Diseases | NA | BeFree | Detail | |
0.002 | Cervical dysplasia | NA | BeFree | Detail | |
0.003 | Uterine Cervical Neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | bile duct adenoma | In contrast, the expression of p16INK4a was seen in most bile duct adenomas and ... | BeFree | 25289642 | Detail |
<0.001 | cholangitis | NA | BeFree | Detail | |
<0.001 | Primary biliary cirrhosis | NA | BeFree | Detail | |
0.005 | Cholangitis, Sclerosing | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | chondrosarcoma | We show that p16/CDKN2A copy number variation occurs subsequent to the IDH1 muta... | BeFree,LHGDN | 25432631 | Detail |
<0.001 | chordoma | Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes... | BeFree | 24983247 | Detail |
0.002 | Congenital chromosomal disease | NA | BeFree | Detail | |
0.008 | ulcerative colitis | Progression from ulcerative colitis (UC) toward colorectal carcinoma (CRC) is mu... | BeFree,LHGDN | 25076849 | Detail |
0.084 | Colonic Neoplasms | NA | BeFree,LHGDN,RGD | Detail | |
0.024 | colorectal carcinoma | Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL... | BeFree | 25015728 | Detail |
0.024 | colorectal carcinoma | Progression from ulcerative colitis (UC) toward colorectal carcinoma (CRC) is mu... | BeFree | 25076849 | Detail |
0.024 | colorectal carcinoma | Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation wit... | BeFree | 25576161 | Detail |
0.024 | colorectal carcinoma | An adenoviral construct of the human p14ARF gene (a tumor suppressor) and a 22 a... | BeFree | 25935465 | Detail |
0.046 | Colorectal Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Condylomata Acuminata | NA | BeFree | Detail | |
<0.001 | Crohn Disease | NA | BeFree | Detail | |
0.007 | adenoid cystic carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | cystadenoma | NA | BeFree | Detail | |
<0.001 | cystitis | NA | BeFree | Detail | |
<0.001 | Phyllodes Tumor | NA | BeFree | Detail | |
<0.001 | Mental Depression | NA | BeFree | Detail | |
<0.001 | depressive disorder | NA | BeFree | Detail | |
0.001 | Diabetes | We review the current knowledge, from studies using human and mouse models, desc... | BeFree | 25744911 | Detail |
0.011 | diabetes mellitus | We review the current knowledge, from studies using human and mouse models, desc... | BeFree,GAD | 25744911 | Detail |
0.003 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,GAD | Detail | |
<0.001 | Diabetic Nephropathy | NA | BeFree | Detail | |
<0.001 | Dwarfism | NA | BeFree | Detail | |
0.007 | dysplastic nevus syndrome | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Eczema | NA | GAD | Detail | |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
0.088 | Endometrial Neoplasms | NA | LHGDN,RGD | Detail | |
<0.001 | endometrial hyperplasia | NA | BeFree | Detail | |
0.038 | Malignant neoplasm of lung | Therefore, we hypothesized that the genetic variants in these three genes influe... | BeFree | 16912209 | Detail |
0.030 | Carcinoma of lung | Therefore, we hypothesized that the genetic variants in these three genes influe... | BeFree | 16912209 | Detail |
0.004 | endometriosis | NA | BeFree,LHGDN | Detail | |
0.002 | Ependymoma | NA | BeFree | Detail | |
<0.001 | erythema nodosum | NA | BeFree | Detail | |
0.222 | Esophageal Neoplasms | Thus, p16 hypermethylation may aid as a biomarker in identifying habitués at gre... | BeFree,CTD_human,GAD,LHGDN,RGD | 25361631 | Detail |
<0.001 | peptic esophagitis | NA | BeFree | Detail | |
<0.001 | Exanthema | Polysomy 6 and p16 deletion were significantly more frequent in noninvasive than... | BeFree | 25517961 | Detail |
<0.001 | Eyelid Neoplasms | Furthermore, p16 overexpression in eyelid SCs was also significantly higher than... | BeFree | 25468813 | Detail |
<0.001 | Fatty Liver | NA | BeFree | Detail | |
0.002 | Fetal Diseases | NA | GAD | Detail | |
<0.001 | fibrosarcoma | NA | BeFree | Detail | |
<0.001 | pathologic fistula | NA | BeFree | Detail | |
<0.001 | Fuchs Endothelial Dystrophy | NA | BeFree | Detail | |
<0.001 | Gall Bladder Diseases | NA | BeFree | Detail | |
0.003 | gallbladder neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | gastrinoma | Deletions of RDINK4/ARF enhancer in gastrinomas and nonfunctioning pancreatic ne... | BeFree | 25003221 | Detail |
<0.001 | gastritis | NA | BeFree | Detail | |
<0.001 | Gastritis, Atrophic | NA | BeFree | Detail | |
0.120 | glaucoma | NA | BeFree,CTD_human | Detail | |
0.023 | glioblastoma | Finally, the G-CIMP+ Ink4a-Arf-/- EGFRvIII glioblastoma line was more resistant ... | BeFree,GAD,LHGDN | 25277177 | Detail |
0.023 | glioblastoma | CD47 activation-induced UHRF1 over-expression is associated with silencing of tu... | BeFree,GAD,LHGDN | 25550546 | Detail |
0.173 | Glioma | Bmi-1 regulates the migration and invasion of glioma cells through p16. | BeFree,CTD_human,GAD,LHGDN | 25262972 | Detail |
0.173 | Glioma | BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of child... | BeFree,CTD_human,GAD,LHGDN | 25667294 | Detail |
0.173 | Glioma | These findings suggest that CDKN2A testing may provide further clinical aid in l... | BeFree,CTD_human,GAD,LHGDN | 25853694 | Detail |
0.173 | Glioma | CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignan... | BeFree,CTD_human,GAD,LHGDN | 25921285 | Detail |
0.173 | Glioma | These findings show that CDKN2 p16 540 C>G, CDKN2 p16 580 C>T and MDM2 SNP309 T>... | BeFree,CTD_human,GAD,LHGDN | 26124340 | Detail |
<0.001 | Glycogen Storage Disease Type VI | NA | BeFree | Detail | |
<0.001 | granulosa cell tumor | NA | BeFree | Detail | |
<0.001 | Graves Disease | NA | BeFree | Detail | |
<0.001 | Hamartoma | NA | BeFree | Detail | |
0.002 | Hay fever | NA | GAD | Detail | |
0.005 | Head and Neck Neoplasms | NA | GAD | Detail | |
<0.001 | cardiac arrest | ECCCs had SCA-like features with rare expression of estrogen receptor/progestero... | BeFree | 25473756 | Detail |
0.005 | Heart Diseases | NA | GAD | Detail | |
<0.001 | hemangiopericytoma | NA | BeFree | Detail | |
0.001 | Hemangiosarcoma | NA | BeFree | Detail | |
0.002 | Hemorrhage | NA | GAD | Detail | |
<0.001 | hepatitis | NA | BeFree | Detail | |
<0.001 | hepatitis A | NA | BeFree | Detail | |
0.012 | hepatitis B | NA | BeFree,LHGDN | Detail | |
<0.001 | Hepatitis, Chronic | NA | BeFree | Detail | |
0.002 | hepatitis C | NA | BeFree | Detail | |
<0.001 | Herpes NOS | NA | BeFree | Detail | |
<0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
<0.001 | Histiocytosis, Langerhans-Cell | Interestingly, all the aggressive cases did not express p16(INK4a), thus suggest... | BeFree | 24471909 | Detail |
0.005 | HIV Infections | Peptides (9mer to 11mer) were designed based on HLA-I-binding algorithms for B*2... | BeFree,GAD | 26322665 | Detail |
0.007 | Hodgkin Disease | NA | BeFree,LHGDN | Detail | |
<0.001 | Huntington disease | NA | BeFree | Detail | |
0.005 | Hypercholesterolemia, Familial | NA | GAD | Detail | |
0.002 | hyperglycemia | NA | GAD | Detail | |
0.080 | Hyperplasia | NA | RGD | Detail | |
0.002 | Hypersensitivity | NA | GAD | Detail | |
0.085 | Hypertensive disease | NA | BeFree,GAD,RGD | Detail | |
<0.001 | pulmonary hypertension | NA | BeFree | Detail | |
0.002 | Insulin resistance | NA | GAD | Detail | |
<0.001 | insulinoma | NA | BeFree | Detail | |
0.003 | keratoacanthoma | NA | BeFree,LHGDN | Detail | |
<0.001 | keratosis | NA | BeFree | Detail | |
0.010 | actinic keratosis | NA | BeFree,LHGDN | Detail | |
<0.001 | seborrheic keratosis | NA | BeFree | Detail | |
<0.001 | Kidney Diseases | NA | BeFree | Detail | |
0.011 | Kidney Failure, Acute | NA | BeFree | Detail | |
0.081 | Kidney Neoplasm | NA | BeFree,RGD | Detail | |
0.121 | Vulvar Lichen Sclerosus | NA | BeFree,CTD_human | Detail | |
0.002 | Laryngeal neoplasm | NA | GAD | Detail | |
0.006 | Fibroid Tumor | NA | BeFree,LHGDN | Detail | |
0.004 | leiomyosarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | tuberculoid leprosy | NA | BeFree | Detail | |
0.022 | leukemia | NA | BeFree,GAD,LHGDN | Detail | |
0.004 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | hairy cell leukemia | NA | BeFree | Detail | |
0.005 | lymphoid leukemia | NA | BeFree,LHGDN | Detail | |
0.020 | Acute lymphocytic leukemia | Deletions of EBF1, IKZF1, and CDKN2A/B have an independent adverse prognosis for... | BeFree | 26194343 | Detail |
0.008 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
<0.001 | acute monocytic leukemia | NA | BeFree | Detail | |
0.017 | Leukemia, Myelocytic, Acute | NA | BeFree,GAD,LHGDN | Detail | |
0.001 | myeloid leukemia | NA | BeFree | Detail | |
0.009 | Myeloid Leukemia, Chronic | NA | BeFree,LHGDN | Detail | |
<0.001 | Leukemia, Myeloid, Chronic-Phase | NA | BeFree | Detail | |
0.001 | Leukemia, Plasma Cell | NA | BeFree | Detail | |
0.001 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
0.003 | Leukemia, T-Cell | NA | BeFree | Detail | |
0.009 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree,GAD | Detail | |
0.003 | Leukoplakia | NA | BeFree,LHGDN | Detail | |
0.003 | Leukoplakia, Oral | NA | BeFree,GAD | Detail | |
0.001 | Lichen Sclerosus et Atrophicus | NA | BeFree | Detail | |
0.004 | liposarcoma | NA | BeFree,LHGDN | Detail | |
0.005 | liver cirrhosis | NA | BeFree,GAD | Detail | |
0.001 | Liver diseases | NA | BeFree | Detail | |
<0.001 | Alcoholic Liver Diseases | NA | BeFree | Detail | |
0.123 | Liver neoplasms | NA | BeFree,CTD_human | Detail | |
<0.001 | Lung diseases | NA | BeFree | Detail | |
0.003 | Chronic Obstructive Airway Disease | NA | BeFree,GAD | Detail | |
0.245 | Lung Neoplasms | NA | BeFree,CTD_human,LHGDN,RGD | Detail | |
<0.001 | Lupus Erythematosus, Systemic | NA | BeFree | Detail | |
<0.001 | Lymphatic Metastasis | NA | BeFree | Detail | |
0.147 | lymphoma | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.005 | Lymphoma, Follicular | NA | BeFree,LHGDN | Detail | |
<0.001 | reticulosarcoma | NA | BeFree | Detail | |
0.002 | Lymphoma, Non-Hodgkin | NA | GAD | Detail | |
<0.001 | Waldenstrom Macroglobulinemia | NA | BeFree | Detail | |
0.019 | Malignant neoplasm of stomach | Cell-cycle regulation was affected by aberrant methylation of CDKN2A and CHFR in... | BeFree,GAD | 24510342 | Detail |
0.019 | Malignant neoplasm of stomach | The present results indicated that the methylation of p16, CDH1, MGMT, and hMLH1... | BeFree,GAD | 24816738 | Detail |
0.019 | Malignant neoplasm of stomach | The relationship between P16 gene promoter methylation and gastric cancer: a met... | BeFree,GAD | 25693938 | Detail |
0.019 | Malignant neoplasm of stomach | ANRIL, a lncRNA co-clustered mainly with p14/ARF has been reported to be dysregu... | BeFree,GAD | 25966845 | Detail |
0.019 | Malignant neoplasm of stomach | Moreover, their combined treatment synergistically arrested GC cells at G0/G1 ph... | BeFree,GAD | 26173505 | Detail |
0.002 | Animal Mammary Neoplasms | NA | GAD | Detail | |
0.080 | Mammary Neoplasms, Experimental | NA | RGD | Detail | |
0.005 | medulloblastoma | NA | BeFree,LHGDN | Detail | |
0.002 | multiple endocrine neoplasia type 1 | NA | GAD | Detail | |
0.014 | meningioma | Progression to a clinically aggressive meningioma is linked to inactivation of C... | BeFree,GAD,LHGDN | 25993161 | Detail |
0.220 | Mesothelioma | NA | BeFree,CTD_human,LHGDN,RGD | Detail | |
<0.001 | Metabolic Diseases | Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic diseas... | BeFree | 25744911 | Detail |
0.003 | Metaplasia | NA | LHGDN | Detail | |
<0.001 | Microphthalmos | NA | BeFree | Detail | |
0.007 | Mixed Salivary Gland Tumor | NA | BeFree,LHGDN | Detail | |
0.001 | Monoclonal Gammopathy of Undetermined Significance | NA | BeFree | Detail | |
0.002 | Monosomy | NA | BeFree | Detail | |
0.013 | Mouth Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
0.134 | multiple myeloma | The cyclin-dependent kinase inhibitor 1 (CDKN2B or p15(INK4B) ) gene lies adjace... | BeFree,CTD_human,LHGDN | 25382971 | Detail |
<0.001 | multiple sclerosis | NA | BeFree | Detail | |
<0.001 | myasthenia gravis | As p16 (CDKN2A), a marker of HPV infections, was up-regulated in MG-T, we thus s... | BeFree | 24440286 | Detail |
0.007 | mycosis fungoides | NA | BeFree,LHGDN | Detail | |
<0.001 | Myeloproliferative disease | Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter ... | BeFree | 25236537 | Detail |
0.002 | Nasopharyngeal Neoplasms | NA | GAD | Detail | |
0.001 | Neck Neoplasms | NA | BeFree | Detail | |
0.120 | Neoplasm Invasiveness | NA | CTD_human | Detail | |
0.034 | Neoplasm Metastasis | Alcohol consumption, location, and features of neck metastasis were correlated w... | BeFree,LHGDN | 24993345 | Detail |
0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
0.003 | multiple endocrine neoplasia | NA | LHGDN | Detail | |
0.007 | Neoplasms, Multiple Primary | NA | GAD | Detail | |
0.003 | nephritis | NA | LHGDN | Detail | |
<0.001 | nephroblastoma | NA | BeFree | Detail | |
0.001 | Nervous System Neoplasms | NA | BeFree | Detail | |
0.003 | neurilemmoma | NA | BeFree,LHGDN | Detail | |
0.129 | neuroblastoma | NA | BeFree,CTD_human,LHGDN | Detail | |
0.002 | neurofibroma | NA | BeFree | Detail | |
0.004 | neurofibromatosis 1 | NA | BeFree,GAD | Detail | |
<0.001 | Neurofibromatosis 2 | NA | BeFree | Detail | |
0.002 | acoustic neuroma | NA | GAD | Detail | |
0.007 | Nevus | NA | BeFree,GAD | Detail | |
0.007 | Melanocytic nevus | NA | BeFree,LHGDN | Detail | |
0.085 | obesity | NA | BeFree,GAD,RGD | Detail | |
0.002 | Occupational Diseases | NA | GAD | Detail | |
0.006 | oligodendroglioma | After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly as... | BeFree,GAD | 25853694 | Detail |
<0.001 | Oropharyngeal Neoplasms | NA | BeFree | Detail | |
0.081 | Degenerative polyarthritis | NA | BeFree,RGD | Detail | |
0.014 | osteosarcoma | Further, we could deduce genes with possible prognostic significance in OS for f... | BeFree,LHGDN | 25848766 | Detail |
0.011 | ovarian carcinoma | NA | BeFree | Detail | |
0.004 | Pancreatic Diseases | NA | BeFree,LHGDN | Detail | |
0.153 | Pancreatic Neoplasm | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | pancreatitis | NA | BeFree | Detail | |
0.005 | papilloma | None of the cell lines showed strong immunopositivity of p16 or presence of huma... | BeFree | 24816148 | Detail |
0.005 | papilloma | Immunohistochemical staining provided diagnostic results for all of the examined... | BeFree | 24914388 | Detail |
0.005 | papilloma | Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker ... | BeFree | 24925218 | Detail |
0.005 | papilloma | Another significant finding was a very poor concordance between p16 expression a... | BeFree | 25339028 | Detail |
0.005 | papilloma | Positivity for HPV DNA (44 samples, 18.9 %) and p16(INK4A) expression (102 sampl... | BeFree | 25575976 | Detail |
0.005 | papilloma | Formalin-fixed, paraffin-embedded material from each case was evaluated for p16 ... | BeFree | 25724573 | Detail |
0.004 | paraganglioma | FGFR1, -2, and -4, VEGFR2, PDGFRα, and p16 were overexpressed in primary human p... | BeFree,LHGDN | 24390213 | Detail |
<0.001 | Extra-Adrenal Paraganglioma | NA | BeFree | Detail | |
0.003 | Parkinson disease | NA | LHGDN | Detail | |
<0.001 | Penile Neoplasms | NA | BeFree | Detail | |
0.005 | periodontitis | NA | GAD,LHGDN | Detail | |
<0.001 | Periodontitis, Juvenile | NA | BeFree | Detail | |
0.120 | Peripheral neuropathy | NA | CTD_human | Detail | |
<0.001 | Peutz-Jeghers syndrome | NA | BeFree | Detail | |
0.002 | Pharyngeal Neoplasms | NA | GAD | Detail | |
0.002 | pheochromocytoma | FGFR1, -2, and -4, VEGFR2, PDGFRα, and p16 were overexpressed in primary human p... | BeFree | 24390213 | Detail |
0.004 | pituitary adenoma | NA | BeFree | Detail | |
0.004 | Pituitary Diseases | NA | BeFree | Detail | |
0.011 | Pituitary Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | plasmacytoma | NA | BeFree | Detail | |
0.004 | Pleural effusion disorder | NA | BeFree,LHGDN | Detail | |
<0.001 | polycythemia vera | NA | BeFree | Detail | |
0.003 | Adenomatous Polyposis Coli | In the present study, the diagnostic utility of the SHOX2 assay was tested with ... | BeFree | 25331797 | Detail |
0.003 | Adenomatous Polyposis Coli | The aim of this study was to investigate promoter methylation of certain tumor s... | BeFree | 25417611 | Detail |
<0.001 | polyps | NA | BeFree | Detail | |
0.013 | Precancerous Conditions | NA | BeFree,GAD | Detail | |
<0.001 | Preleukemia | NA | BeFree | Detail | |
0.009 | Prostatic Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder) | Sequence analysis demonstrated a known deleterious mutation in CDKN2A (G-34T) an... | BeFree | 18025365 | Detail |
<0.001 | Protein Deficiency | The prime aim of this study was to evaluate the mismatch-repair (MMR)-protein de... | BeFree | 25457183 | Detail |
0.002 | psoriasis | NA | BeFree | Detail | |
<0.001 | pterygium | NA | BeFree | Detail | |
<0.001 | pulmonary emphysema | NA | BeFree | Detail | |
<0.001 | Rectal polyp | NA | BeFree | Detail | |
0.029 | retinoblastoma | The aim was to explore putative differences in p16(INK) (4a) -retinoblastoma (Rb... | BeFree,LHGDN | 25123601 | Detail |
0.088 | rhabdomyosarcoma | NA | BeFree,LHGDN,RGD | Detail | |
0.001 | schistosomiasis | NA | BeFree | Detail | |
0.002 | schizophrenia | NA | GAD | Detail | |
<0.001 | Sebaceous Gland Neoplasms | The prime aim of this study was to evaluate the mismatch-repair (MMR)-protein de... | BeFree | 25457183 | Detail |
<0.001 | seminoma | NA | BeFree | Detail | |
0.123 | Sezary syndrome | NA | CTD_human,LHGDN | Detail | |
<0.001 | silicosis | NA | BeFree | Detail | |
<0.001 | Dermatologic disorders | NA | BeFree | Detail | |
0.042 | Skin Neoplasms | NA | BeFree,GAD | Detail | |
<0.001 | Soft Tissue Neoplasms | NA | BeFree | Detail | |
0.002 | Starvation | NA | GAD | Detail | |
0.210 | Stomach Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN,RGD | Detail | |
0.008 | Cerebrovascular accident | NA | BeFree,GAD | Detail | |
0.002 | Sunburn | NA | GAD | Detail | |
<0.001 | Supratentorial Neoplasms | NA | BeFree | Detail | |
0.001 | synovial sarcoma | NA | BeFree | Detail | |
0.003 | teratoma | NA | LHGDN | Detail | |
<0.001 | Testicular Neoplasms | NA | BeFree | Detail | |
0.121 | thymoma | As p16 (CDKN2A), a marker of HPV infections, was up-regulated in MG-T, we thus s... | BeFree,CTD_human | 24440286 | Detail |
0.007 | Thyroid Neoplasm | NA | BeFree,LHGDN | Detail | |
0.080 | Tongue Neoplasms | NA | RGD | Detail | |
0.120 | Chromosomal translocation | NA | CTD_human | Detail | |
0.002 | Chagas disease | NA | GAD | Detail | |
<0.001 | tuberous sclerosis | NA | BeFree | Detail | |
<0.001 | Unipolar Depression | NA | BeFree | Detail | |
0.120 | Genitourinary Neoplasms | NA | CTD_human | Detail | |
<0.001 | Urologic Diseases | NA | BeFree | Detail | |
<0.001 | Uterine Fibroids | NA | BeFree | Detail | |
0.002 | Uveal Neoplasms | NA | GAD | Detail | |
<0.001 | Malignant Vaginal Neoplasm | NA | BeFree | Detail | |
0.003 | Vascular Diseases | NA | BeFree,GAD | Detail | |
0.001 | Virus Diseases | NA | BeFree | Detail | |
<0.001 | xeroderma pigmentosum | NA | BeFree | Detail | |
<0.001 | Hallopeau-Siemens Disease | NA | BeFree | Detail | |
<0.001 | Ichthyosis, X-Linked | NA | BeFree | Detail | |
0.012 | B-Cell Lymphomas | NA | BeFree,LHGDN | Detail | |
<0.001 | High Grade Lymphoma (neoplasm) | NA | BeFree | Detail | |
0.125 | diffuse large B-cell lymphoma | NA | BeFree,CTD_human | Detail | |
<0.001 | Immunoblastic Large-Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | Low Grade Lymphoma (neoplasm) | NA | BeFree | Detail | |
0.001 | T-Cell Lymphoma | Our findings demonstrate that while deletions on chromosomes 4 and 11 affecting ... | BeFree | 26141385 | Detail |
0.121 | Lymphoma, T-Cell, Cutaneous | NA | BeFree,CTD_human | Detail | |
0.001 | Pleural Effusion, Malignant | NA | BeFree | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
0.005 | Neoplasms, Second Primary | NA | BeFree,GAD | Detail | |
<0.001 | gestational diabetes | NA | BeFree | Detail | |
0.001 | Li-Fraumeni syndrome | NA | BeFree | Detail | |
<0.001 | Neurofibrillary degeneration (morphologic abnormality) | NA | BeFree | Detail | |
0.004 | acute leukemia | p19ARF is a critical mediator of both cellular senescence and an innate immune r... | BeFree | 25784651 | Detail |
<0.001 | Chronic cholecystitis | NA | BeFree | Detail | |
<0.001 | Chronic gastritis | NA | BeFree | Detail | |
0.002 | benign neoplasm | NA | BeFree | Detail | |
<0.001 | Rous Sarcoma | NA | BeFree | Detail | |
<0.001 | Sicca Syndrome | NA | BeFree | Detail | |
0.007 | Pancreatitis, Chronic | NA | BeFree,LHGDN | Detail | |
0.002 | Epstein-Barr Virus Infections | NA | BeFree | Detail | |
0.002 | Squamous cell carcinoma of lung | Correlation between squamous cell carcinoma of the lung and human papillomavirus... | BeFree | 25544708 | Detail |
0.004 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Atrophic condition of skin | NA | BeFree | Detail | |
0.003 | Oral Cavity Carcinoma | NA | BeFree,GAD | Detail | |
0.144 | Cutaneous Melanoma | This is the first estimate of the contribution of BAP1 and CDK4 to a population-... | BeFree,CTD_human,GAD | 25787093 | Detail |
0.144 | Cutaneous Melanoma | To conclude, we propose that mutation screening of CDKN2A and CDK4 in Denmark sh... | BeFree,CTD_human,GAD | 25803691 | Detail |
0.002 | Adenocarcinoma of lung (disorder) | Two-hit inactivation of CDKN2A and CDKN2B occurs frequently in patients with mut... | BeFree | 24618618 | Detail |
0.005 | esophageal carcinoma | Thus, p16 hypermethylation may aid as a biomarker in identifying habitués at gre... | BeFree | 25361631 | Detail |
<0.001 | congenital heart disease | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of tongue | Risk stratification of early stage oral tongue cancers based on HPV status and p... | BeFree | 25339028 | Detail |
0.005 | Malignant neoplasm of mouth | NA | BeFree | Detail | |
0.004 | Malignant neoplasm of oropharynx | The majority of North American respondents in this survey systematically test fo... | BeFree | 25096827 | Detail |
0.004 | Malignant neoplasm of oropharynx | Interestingly, the prognostic significance of p16 overexpression is different fr... | BeFree | 25339028 | Detail |
0.004 | Malignant neoplasm of oropharynx | Among these biomarkers, p53 is the strongest prognostic marker in OPC and p53 in... | BeFree | 25380690 | Detail |
0.004 | Malignant neoplasm of oropharynx | Significant correlations were confirmed between p16 positivity and oropharyngeal... | BeFree | 25503184 | Detail |
0.004 | Malignant neoplasm of oropharynx | Overall, this study provides evidence of epigenetic changes to the downstream re... | BeFree | 25619363 | Detail |
0.004 | Malignant neoplasm of oropharynx | Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southea... | BeFree | 26152733 | Detail |
<0.001 | Malignant neoplasm of nasopharynx | We here evaluated p16 INK4A as a prognostic marker of treatment response and sur... | BeFree | 25640361 | Detail |
<0.001 | Hypopharyngeal Cancer | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of anus | We evaluated combined HPV DNA and p16 status as a prognostic factor of treatment... | BeFree | 26530750 | Detail |
0.001 | Malignant neoplasm of gallbladder | NA | BeFree | Detail | |
<0.001 | uterine cancer | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of penis | Thus, patients with P16(ink4a) negative penile cancer, particularly those with l... | BeFree | 25261804 | Detail |
<0.001 | Malignant neoplasm of brain | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
0.002 | Malnutrition | NA | GAD | Detail | |
0.003 | Neurofibromatoses | NA | BeFree,LHGDN | Detail | |
<0.001 | Agenesis of corpus callosum | NA | BeFree | Detail | |
<0.001 | Autoimmune thyroid disease | NA | BeFree | Detail | |
<0.001 | Glomerulosclerosis (disorder) | NA | BeFree | Detail | |
0.024 | Tumor Progression | HPV infection appears to be involved in cancer progression in SQC by promoting t... | BeFree | 25544708 | Detail |
<0.001 | Microinvasive tumor | NA | BeFree | Detail | |
<0.001 | follicular adenoma | NA | BeFree | Detail | |
<0.001 | Carcinoma, Spindle-Cell | Copy number analyses by molecular inversion probe assays of the three spindle ce... | BeFree | 25713418 | Detail |
0.001 | Undifferentiated carcinoma | NA | BeFree | Detail | |
0.003 | Familial Atypical Multiple Mole-Melanoma | The p16-Leiden founder mutation in the CDKN2A gene is the most common cause of F... | BeFree | 26111702 | Detail |
0.007 | Dysplastic Nevus | NA | BeFree,GAD | Detail | |
<0.001 | Liposarcoma, Dedifferentiated | NA | BeFree | Detail | |
0.001 | Germ cell tumor | NA | BeFree | Detail | |
<0.001 | Glandular Neoplasms | NA | BeFree | Detail | |
<0.001 | thymic carcinoma | NA | BeFree | Detail | |
<0.001 | Lichen Planus, Oral | NA | BeFree | Detail | |
<0.001 | Ki-1+ Anaplastic Large Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | hepatoblastoma | NA | BeFree | Detail | |
<0.001 | Fibroadenoma | NA | BeFree | Detail | |
<0.001 | Sarcoma, Clear Cell | NA | BeFree | Detail | |
<0.001 | alveolar rhabdomyosarcoma | NA | BeFree | Detail | |
0.007 | embryonal carcinoma | NA | BeFree | Detail | |
<0.001 | germinoma | NA | BeFree | Detail | |
0.004 | Neuroectodermal Tumor, Primitive | NA | BeFree,LHGDN | Detail | |
<0.001 | teratocarcinoma | NA | BeFree | Detail | |
<0.001 | hepatocellular adenoma | NA | BeFree | Detail | |
<0.001 | Follicular thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | sebaceous adenocarcinoma | Nevertheless, p16 overexpression was found in 71.4% (10/14) of SCs, irrespective... | BeFree | 25468813 | Detail |
0.120 | adrenocortical carcinoma | NA | BeFree,CTD_human | Detail | |
0.001 | Carcinoma, Endometrioid | ECCCs had SCA-like features with rare expression of estrogen receptor/progestero... | BeFree | 25473756 | Detail |
<0.001 | mucoepidermoid carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma, Neuroendocrine | NA | BeFree | Detail | |
<0.001 | Carcinoma, Signet Ring Cell | NA | BeFree | Detail | |
0.008 | cholangiocarcinoma | Exome and the following prevalence sequencing identified mutations of the BAP1, ... | BeFree,GAD,LHGDN | 24532422 | Detail |
<0.001 | Cystadenocarcinoma, Mucinous | NA | BeFree | Detail | |
0.003 | Cystadenocarcinoma, Serous | NA | BeFree,GAD | Detail | |
<0.001 | Carcinoma, Large Cell | NA | BeFree | Detail | |
0.002 | verrucous carcinoma | β-PV DNA was detected in 5/30 VC (16.7%) and in 18/30 normal tissue samples (60.... | BeFree | 24350715 | Detail |
0.002 | verrucous carcinoma | Diffuse p16 expression was associated with younger age at presentation (P<0.0001... | BeFree | 26171917 | Detail |
0.019 | Cervical Intraepithelial Neoplasia | In this study, high-risk HPV E6/E7 and p16 mRNA expression patterns in eighty-si... | BeFree,LHGDN | 24625757 | Detail |
0.019 | Cervical Intraepithelial Neoplasia | We also used immunohistochemistry (IHC) to detect the P16(INK4a) protein, the ex... | BeFree,LHGDN | 25120798 | Detail |
0.019 | Cervical Intraepithelial Neoplasia | Immunohistochemistry of p16INK4A staining shows nil (0/25) expression in the cer... | BeFree,LHGDN | 25361681 | Detail |
0.019 | Cervical Intraepithelial Neoplasia | P16INK4A and survivin: Diagnostic and prognostic markers in cervical intraepithe... | BeFree,LHGDN | 25910412 | Detail |
0.019 | Cervical Intraepithelial Neoplasia | PanHPVE4 and p16INK4a staining are complementary markers that could provide simp... | BeFree,LHGDN | 26379150 | Detail |
<0.001 | Cystadenoma, Serous | NA | BeFree | Detail | |
<0.001 | Mucoepidermoid Tumor | NA | BeFree | Detail | |
<0.001 | ganglioglioma | NA | BeFree | Detail | |
<0.001 | inverted papilloma | NA | BeFree | Detail | |
<0.001 | gliosarcoma | NA | BeFree | Detail | |
0.124 | Nerve Sheath Tumors | NA | BeFree,CTD_human,LHGDN | Detail | |
0.003 | Melanoma, Amelanotic | NA | BeFree,GAD | Detail | |
0.007 | Rhabdoid Tumor | NA | BeFree,LHGDN | Detail | |
<0.001 | Neuroendocrine Tumors | NA | BeFree | Detail | |
<0.001 | childhood rhabdomyosarcoma | NA | BeFree | Detail | |
<0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
0.006 | uveal melanoma | Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal m... | BeFree,GAD | 25497382 | Detail |
0.007 | Lip and oral cavity carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | Carcinoma of unknown primary | NA | BeFree | Detail | |
<0.001 | Metastatic malignant neoplasm to brain | CDKN2A/B deletions were associated with multiple MBMs and frequently hypermethyl... | BeFree | 24968695 | Detail |
<0.001 | Chondromyxoid fibroma | NA | BeFree | Detail | |
0.003 | pituitary-dependent Cushing's disease | NA | LHGDN | Detail | |
<0.001 | Premature aging syndrome | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of female breast | NA | BeFree | Detail | |
0.001 | gallbladder carcinoma | NA | BeFree | Detail | |
0.028 | pancreatic carcinoma | Increasing knowledge about the molecular pathogenesis of the disease has shown t... | BeFree | 24976721 | Detail |
0.028 | pancreatic carcinoma | Our results strongly support that the deletion of RD may represent a novel mecha... | BeFree | 25003221 | Detail |
0.028 | pancreatic carcinoma | Our results show that the clinical candidate AKT inhibitor MK-2206 promotes ARF ... | BeFree | 25071014 | Detail |
0.028 | pancreatic carcinoma | Studies of the molecular pathology of pancreatic cancer have revealed that activ... | BeFree | 25152585 | Detail |
0.028 | pancreatic carcinoma | The p16-Leiden germline variant in the CDKN2A gene is associated with a high ris... | BeFree | 25227142 | Detail |
0.028 | pancreatic carcinoma | This review presents current evidence regarding both senescence induction and es... | BeFree | 25461770 | Detail |
0.013 | Gastrointestinal Stromal Tumors | NA | BeFree,LHGDN | Detail | |
<0.001 | Cancer of Nasopharynx | We here evaluated p16 INK4A as a prognostic marker of treatment response and sur... | BeFree | 25640361 | Detail |
0.002 | Squamous cell carcinoma of penis | Lack of P16ink4a over expression in penile squamous cell carcinoma is associated... | BeFree | 25261804 | Detail |
0.002 | Squamous cell carcinoma of penis | HR-HPV(+) PSCCs overexpressed p16(INK4a) in 88% cases and p53 in 35% of cases, w... | BeFree | 25455689 | Detail |
0.002 | Squamous cell carcinoma of penis | The role of histologic subtype, p16(INK4a) expression, and presence of human pap... | BeFree | 25885064 | Detail |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of the vagina | NA | BeFree | Detail | |
<0.001 | Fibrosis, Liver | NA | BeFree | Detail | |
<0.001 | Interstitial fibrosis | NA | BeFree | Detail | |
<0.001 | Hepatitis, Autoimmune | NA | BeFree | Detail | |
<0.001 | islet cell tumor | NA | BeFree | Detail | |
0.038 | Malignant neoplasm of lung | Furthermore, comparative analysis of mutant Kras;Cdkn2a null with Kras;Cdkn2ab n... | BeFree,GAD | 24618618 | Detail |
0.038 | Malignant neoplasm of lung | A cross-sectional study was conducted in which the methylation status of DAPK, C... | BeFree,GAD | 25069886 | Detail |
0.038 | Malignant neoplasm of lung | In the present study, the diagnostic utility of the SHOX2 assay was tested with ... | BeFree,GAD | 25331797 | Detail |
0.038 | Malignant neoplasm of lung | ANRIL, a lncRNA co-clustered mainly with p14/ARF has been reported to be dysregu... | BeFree,GAD | 25966845 | Detail |
0.003 | Neoplasm, Residual | NA | BeFree,LHGDN | Detail | |
<0.001 | Isochromosomes | NA | BeFree | Detail | |
0.005 | Mucosa-Associated Lymphoid Tissue Lymphoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Malignant Meningioma | NA | BeFree | Detail | |
<0.001 | Multiple tumors | NA | BeFree | Detail | |
0.005 | Carcinoma, Small Cell | NA | BeFree,LHGDN | Detail | |
<0.001 | parathyroid adenoma | NA | BeFree | Detail | |
<0.001 | Vagina Carcinoma | NA | BeFree | Detail | |
<0.001 | spongiotic dermatitis | NA | BeFree | Detail | |
<0.001 | Psoriasis vulgaris | NA | BeFree | Detail | |
0.011 | Acute respiratory failure | NA | BeFree | Detail | |
<0.001 | Renal sclerosis with hypertension | NA | BeFree | Detail | |
<0.001 | Secondary pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Turcot syndrome (disorder) | NA | BeFree | Detail | |
<0.001 | Chronic Periodontitis | NA | BeFree | Detail | |
<0.001 | Gastric dysplasia | NA | BeFree | Detail | |
<0.001 | Superficial gastritis | NA | BeFree | Detail | |
<0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
<0.001 | Non-small cell lung cancer stage I | NA | BeFree | Detail | |
<0.001 | Non-small cell lung cancer stage II | NA | BeFree | Detail | |
<0.001 | recurrent childhood acute lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | extramedullary plasmacytoma | NA | BeFree | Detail | |
<0.001 | Neuroblastoma recurrent | NA | BeFree | Detail | |
0.002 | gastric adenocarcinoma | NA | BeFree | Detail | |
0.001 | Malignant Childhood Neoplasm | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of small intestine | NA | BeFree | Detail | |
<0.001 | Growth Hormone-Producing Pituitary Gland Neoplasm | NA | BeFree | Detail | |
0.002 | Metastatic melanoma | BRAF mutation and CDKN2A loss occurred early and TERT promoter mutation later in... | BeFree | 25407517 | Detail |
<0.001 | Non-small cell lung cancer metastatic | NA | BeFree | Detail | |
0.015 | Cancer of Head and Neck | Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head a... | BeFree,GAD | 24710824 | Detail |
0.015 | Cancer of Head and Neck | Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction... | BeFree,GAD | 25557267 | Detail |
0.015 | Cancer of Head and Neck | P16(INK4A) expression and HGAOT are independent prognostic factors for OS of pat... | BeFree,GAD | 25575976 | Detail |
0.015 | Cancer of Head and Neck | HPV-associated p16 INK4A expression and response to therapy and survival in sele... | BeFree,GAD | 25640361 | Detail |
0.015 | Cancer of Head and Neck | p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Adv... | BeFree,GAD | 25810339 | Detail |
0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
0.001 | T-cell childhood acute lymphoblastic leukemia | NA | BeFree | Detail | |
0.133 | Squamous cell carcinoma of esophagus | The results of this study suggested that MDM2 and p16 are predictive markers for... | BeFree,CTD_human,GAD | 25880782 | Detail |
0.125 | Adenocarcinoma Of Esophagus | Reanalysis of additional EAC exome data showed that the majority (62.5%) of EACs... | BeFree,CTD_human | 26192918 | Detail |
<0.001 | anal carcinoma | We evaluated combined HPV DNA and p16 status as a prognostic factor of treatment... | BeFree | 26530750 | Detail |
<0.001 | gallbladder adenocarcinoma | These results indicate that p16, p63 and p53 can be used as prognostic markers i... | BeFree | 24178677 | Detail |
0.001 | cervical squamous cell carcinoma | P16INK4A and survivin: Diagnostic and prognostic markers in cervical intraepithe... | BeFree | 25910412 | Detail |
<0.001 | cervical adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Small cell carcinoma of the cervix | NA | BeFree | Detail | |
<0.001 | Transitional cell carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | bladder squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | bladder adenocarcinoma | The expression patterns of p53 and p16 and an analysis of a possible role of HPV... | BeFree | 24752337 | Detail |
<0.001 | Conventional (Clear Cell) Renal Cell Carcinoma | Changes in PTEN and CDKN2A gene sets were associated with worsened prognosis of ... | BeFree | 25853938 | Detail |
<0.001 | extraosseous Ewings sarcoma-primitive neuroepithelial tumor | NA | BeFree | Detail | |
0.004 | Solid tumour | NA | BeFree | Detail | |
<0.001 | stage, non-small cell lung cancer | NA | BeFree | Detail | |
0.007 | Squamous cell carcinoma of oropharynx | The combination of both HPV-DNA sequencing analysis and immunohistochemistry (IH... | BeFree | 25399886 | Detail |
0.007 | Squamous cell carcinoma of oropharynx | We assessed a population-based cohort of patients diagnosed with oropharyngeal s... | BeFree | 26152733 | Detail |
0.007 | Squamous cell carcinoma of oropharynx | The authors explored the prognostic significance of heregulin/HER3 expression in... | BeFree | 26195293 | Detail |
0.001 | Squamous cell carcinoma of tonsil | We applied HPV DNA PCR and p16 immunohistochemistry to all TSCCs registered in t... | BeFree | 25283302 | Detail |
0.003 | laryngeal squamous cell carcinoma | P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis... | BeFree | 25652585 | Detail |
0.003 | laryngeal squamous cell carcinoma | Frequency and prognostic significance of p16(INK4A) protein overexpression and t... | BeFree | 25688737 | Detail |
<0.001 | high-grade childhood cerebral astrocytoma | NA | BeFree | Detail | |
<0.001 | diffuse astrocytoma | NA | BeFree | Detail | |
<0.001 | anaplastic ependymoma | NA | BeFree | Detail | |
<0.001 | mixed oligodendroglioma-astrocytoma | After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly as... | BeFree | 25853694 | Detail |
<0.001 | Primary central nervous system lymphoma | NA | BeFree | Detail | |
0.002 | Squamous cell carcinoma of vulva | p16INK4A expression could be used as a useful marker for HPV positivity in vagin... | BeFree | 25605180 | Detail |
0.004 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
<0.001 | benign meningioma | NA | BeFree | Detail | |
<0.001 | Myomatous neoplasm | NA | BeFree | Detail | |
<0.001 | Condyloma | NA | BeFree | Detail | |
0.016 | cervix carcinoma | Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker ... | BeFree | 24925218 | Detail |
0.016 | cervix carcinoma | Immunohistochemistry of p16INK4A staining shows nil (0/25) expression in the cer... | BeFree | 25361681 | Detail |
0.016 | cervix carcinoma | Medline, Embase and China National Knowledge Infrastructures were searched to id... | BeFree | 25461355 | Detail |
0.016 | cervix carcinoma | Methylation of the p16(INK4a) gene occurs early in the development of cervical c... | BeFree | 25579180 | Detail |
0.016 | cervix carcinoma | p16INK4A expression could be used as a useful marker for HPV positivity in vagin... | BeFree | 25605180 | Detail |
0.016 | cervix carcinoma | Moreover, p16 protein was associated with CIN grade and lymph node metastases in... | BeFree | 25910412 | Detail |
<0.001 | Superficial ulcer | NA | BeFree | Detail | |
0.001 | Tumor necrosis | NA | BeFree | Detail | |
0.002 | Squamous intraepithelial lesion | NA | BeFree | Detail | |
0.007 | High-Grade Squamous Intraepithelial Lesions | The combination TOP2A and CDKN2A/p16 has a good balance between sensitivity and ... | BeFree | 25189639 | Detail |
0.007 | High-Grade Squamous Intraepithelial Lesions | A marker with high sensitivity and specificity for the detection of HSIL in cerv... | BeFree | 25862555 | Detail |
0.001 | Hyperplastic Polyp | NA | BeFree | Detail | |
<0.001 | Multiple polyps | NA | BeFree | Detail | |
<0.001 | Papillary squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma, metastatic | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma, keratinizing | NA | BeFree | Detail | |
<0.001 | Transitional cell carcinoma in situ | NA | BeFree | Detail | |
<0.001 | adenocarcinoma in situ | NA | BeFree | Detail | |
<0.001 | tubular adenomas and adenocarcinomas | NA | BeFree | Detail | |
<0.001 | Carcinoid tumor no ICD-O subtype | NA | BeFree | Detail | |
<0.001 | Nodular melanoma | NA | BeFree | Detail | |
<0.001 | Superficial spreading malignant melanoma of skin | Compared with CDKN2A(-) cases, mutation carriers tended to have histologic featu... | BeFree | 25592620 | Detail |
0.003 | malignant fibrous histiocytoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Proliferating Brenner Tumor | NA | BeFree | Detail | |
<0.001 | myxoid chondrosarcoma | NA | BeFree | Detail | |
0.003 | anaplastic astrocytoma | NA | BeFree | Detail | |
0.002 | pilocytic astrocytoma | NA | BeFree | Detail | |
0.004 | anaplastic oligodendroglioma | Within the 1p/19q-codeleted AO, the contrast enhancement was associated with lar... | BeFree | 24353325 | Detail |
0.004 | anaplastic oligodendroglioma | After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly as... | BeFree | 25853694 | Detail |
0.006 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A an... | BeFree,LHGDN | 26022239 | Detail |
<0.001 | histiocytic sarcoma | NA | BeFree | Detail | |
<0.001 | Glaucoma, Primary Open Angle | Evaluation of genetic association of the INK4 locus with primary open angle glau... | BeFree | 24875940 | Detail |
<0.001 | Internal Carotid Artery Stenosis | The severity of internal carotid artery stenosis is associated with the cyclin-d... | BeFree | 24599170 | Detail |
<0.001 | Aortic aneurysm without mention of rupture NOS | NA | BeFree | Detail | |
0.004 | Human papilloma virus infection | Detection of human papillomavirus infection and p16 immunohistochemistry express... | BeFree | 24675970 | Detail |
0.004 | Human papilloma virus infection | Correlation between squamous cell carcinoma of the lung and human papillomavirus... | BeFree | 25544708 | Detail |
0.004 | Human papilloma virus infection | Frequency and prognostic significance of p16(INK4A) protein overexpression and t... | BeFree | 25688737 | Detail |
<0.001 | Carcinoma ex pleomorphic adenoma | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | intrahepatic cholangiocarcinoma | Given overexpression of a polycomb group protein EZH2 in intrahepatic cholangioc... | BeFree | 25289642 | Detail |
<0.001 | Angiosarcoma of liver | NA | BeFree | Detail | |
0.005 | malignant mesothelioma | NA | BeFree | Detail | |
<0.001 | Stage 0 Skin Melanoma | NA | BeFree | Detail | |
0.003 | Vulval intraepithelial neoplasia | Diffuse p16 expression was associated with younger age at presentation (P<0.0001... | BeFree | 26171917 | Detail |
<0.001 | Malignant melanoma of iris | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of adrenal cortex | NA | BeFree | Detail | |
0.035 | Malignant neoplasm of pancreas | Increasing knowledge about the molecular pathogenesis of the disease has shown t... | BeFree,GAD | 24976721 | Detail |
0.035 | Malignant neoplasm of pancreas | Our results strongly support that the deletion of RD may represent a novel mecha... | BeFree,GAD | 25003221 | Detail |
0.035 | Malignant neoplasm of pancreas | Our results show that the clinical candidate AKT inhibitor MK-2206 promotes ARF ... | BeFree,GAD | 25071014 | Detail |
0.035 | Malignant neoplasm of pancreas | Studies of the molecular pathology of pancreatic cancer have revealed that activ... | BeFree,GAD | 25152585 | Detail |
0.035 | Malignant neoplasm of pancreas | The p16-Leiden germline variant in the CDKN2A gene is associated with a high ris... | BeFree,GAD | 25227142 | Detail |
0.035 | Malignant neoplasm of pancreas | This review presents current evidence regarding both senescence induction and es... | BeFree,GAD | 25461770 | Detail |
<0.001 | Disseminated Malignant Neoplasm | NA | BeFree | Detail | |
0.002 | Anal intraepithelial neoplasia | NA | BeFree | Detail | |
<0.001 | Carcinoma in situ of fallopian tube | Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intr... | BeFree | 26206555 | Detail |
<0.001 | Penile intraepithelial neoplasia | NA | BeFree | Detail | |
<0.001 | Cervix adenomatous polyp | NA | BeFree | Detail | |
0.005 | Cervical intraepithelial neoplasia grade 1 | NA | BeFree | Detail | |
0.005 | Cervical intraepithelial neoplasia grade 2 | Compared with high-risk HPV genotyping, p16(INK4a)/Ki-67 immunocytochemistry was... | BeFree | 24744261 | Detail |
<0.001 | gastric lymphoma | NA | BeFree | Detail | |
<0.001 | Carcinoma of anal margin | By contrast, p16 negatively, but not HPV 16 genotype, is an independent adverse ... | BeFree | 25702585 | Detail |
<0.001 | Vaginal intraepithelial neoplasia grade 1 | NA | BeFree | Detail | |
<0.001 | Vulval intraepithelial neoplasia grade 3 | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of tongue | To combine clinical and molecular markers into an algorithm for predicting outco... | BeFree | 26025766 | Detail |
<0.001 | Pleomorphic adenoma of parotid gland | NA | BeFree | Detail | |
<0.001 | Richter's syndrome | NA | BeFree | Detail | |
<0.001 | juvenile myelomonocytic leukemia | NA | BeFree | Detail | |
0.002 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
<0.001 | Human T-cell lymphotrophic virus, type I [HTLV-I] | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of vulva | NA | BeFree | Detail | |
0.006 | Malignant neoplasm of prostate | Association of p16 gene methylation with prostate cancer risk: a meta-analysis. | BeFree | 26416059 | Detail |
0.002 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
0.007 | Hematologic Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | Hereditary hemochromatosis | NA | BeFree | Detail | |
0.360 | melanoma | An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility... | BeFree | 12406345 | Detail |
0.002 | Benign melanocytic nevus | An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility... | BeFree | 12406345 | Detail |
<0.001 | Nijmegen breakage syndrome | NA | BeFree | Detail | |
0.144 | Cutaneous Melanoma | The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Bra... | BeFree | 21895773 | Detail |
0.360 | melanoma | The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Bra... | BeFree | 21895773 | Detail |
0.007 | Nevus | An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility... | BeFree | 12406345 | Detail |
0.023 | breast carcinoma | In the total set of 189 patients we found a novel change Pro48Arg (nt 143 c >... | BeFree | 18714178 | Detail |
0.007 | Melanocytic nevus | An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility... | BeFree | 12406345 | Detail |
0.001 | Melanocytic nevus of skin | An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility... | BeFree | 12406345 | Detail |
0.023 | breast carcinoma | The CDKN2A A148T variant seems to contribute to early-onset breast cancer in Pol... | BeFree | 17061045 | Detail |
0.360 | melanoma | The CDKN2a common variants: 148 Ala/Thr and 500 C/G in 3' UTR, and their associa... | BeFree | 17351674 | Detail |
0.043 | Malignant neoplasm of breast | In the total set of 189 patients we found a novel change Pro48Arg (nt 143 c >... | BeFree | 18714178 | Detail |
0.360 | melanoma | In the total set of 189 patients we found a novel change Pro48Arg (nt 143 c >... | BeFree | 18714178 | Detail |
<0.001 | Chronic rejection of renal transplant | NA | BeFree | Detail | |
<0.001 | Poikiloderma of Kindler | NA | BeFree | Detail | |
<0.001 | Developmental delay (disorder) | NA | BeFree | Detail | |
<0.001 | Atypical meningioma | NA | BeFree | Detail | |
<0.001 | Chromosome 9, trisomy | NA | BeFree | Detail | |
<0.001 | Post-transplant lymphoproliferative disorder | NA | BeFree | Detail | |
<0.001 | Follicular neoplasm | NA | BeFree | Detail | |
<0.001 | Plasma cell tumor, malignant | NA | BeFree | Detail | |
0.004 | endometrial carcinoma | Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma. | BeFree | 25596080 | Detail |
0.002 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
0.002 | physical function | NA | GAD | Detail | |
<0.001 | Sleep Apnea, Obstructive | NA | BeFree | Detail | |
0.002 | Recurrent tumor | NA | BeFree | Detail | |
<0.001 | Neurodegenerative Disorders | NA | BeFree | Detail | |
<0.001 | Hepatitis C, Chronic | NA | BeFree | Detail | |
0.010 | Malignant neoplasm of esophagus | Thus, p16 hypermethylation may aid as a biomarker in identifying habitués at gre... | BeFree,GAD | 25361631 | Detail |
<0.001 | Recurrent Carcinoma | NA | BeFree | Detail | |
0.003 | Thyroid carcinoma | NA | BeFree | Detail | |
0.004 | Oropharynx (excludes nasopharynx) | In total, 24% of the HNSCCUP patients were p16 positive. p16 overexpression in n... | BeFree | 24993345 | Detail |
0.004 | Oropharynx (excludes nasopharynx) | No association between KRAS-variant status and p16 expression was observed in th... | BeFree | 25081901 | Detail |
0.004 | Oropharynx (excludes nasopharynx) | Among those HNSCCs that were positive for HR-HPV, 18 (100%) of 18 originated fro... | BeFree | 25873503 | Detail |
0.004 | Oropharynx (excludes nasopharynx) | HPV E7 seropositivity correlated with positive tumor HPV-DNA and p16 expression,... | BeFree | 26116154 | Detail |
0.003 | Ewings sarcoma | Strikingly, STAG2 mutations and CDKN2A deletions were mutually exclusive, as con... | BeFree | 25223734 | Detail |
0.003 | Ewings sarcoma | A growing collection of retrospective studies have suggested that TP53 mutations... | BeFree | 25464386 | Detail |
0.005 | Oropharyngeal disorders | MiR-34a tumor levels significantly correlated with oropharyngeal origin (p=0.028... | BeFree | 25862914 | Detail |
0.005 | Oropharyngeal disorders | Immunohistochemistry for p16 protein is often used as a surrogate marker for onc... | BeFree | 26650695 | Detail |
0.002 | Squamous cell carcinoma of skin | NA | BeFree | Detail | |
0.006 | Malignant glioma | NA | BeFree | Detail | |
<0.001 | tongue carcinoma | Risk stratification of early stage oral tongue cancers based on HPV status and p... | BeFree | 25339028 | Detail |
0.001 | Tonsillar Carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant melanoma of eye | NA | BeFree | Detail | |
<0.001 | primary sclerosing cholangitis | NA | BeFree | Detail | |
<0.001 | Carotid Atherosclerosis | In addition, the p16(INK4a) expression is associated with carotid atherosclerosi... | BeFree | 24599170 | Detail |
<0.001 | Squamous cell carcinoma of mouth | NA | BeFree | Detail | |
0.005 | Osteosarcoma of bone | Further, we could deduce genes with possible prognostic significance in OS for f... | BeFree | 25848766 | Detail |
<0.001 | Costello syndrome (disorder) | The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer... | BeFree | 26138095 | Detail |
<0.001 | Intraocular pressure disorder | Our data indicate that SIX6 and/or IOP promotes POAG by directly increasing p16I... | BeFree | 26365380 | Detail |
0.028 | pancreatic carcinoma | To verify the S305N association with melanoma risk in an independent larger Fren... | BeFree | 21507037 | Detail |
<0.001 | Carcinoma of larynx | NA | BeFree | Detail | |
0.360 | melanoma | To verify the S305N association with melanoma risk in an independent larger Fren... | BeFree | 21507037 | Detail |
0.035 | Malignant neoplasm of pancreas | To verify the S305N association with melanoma risk in an independent larger Fren... | BeFree | 21507037 | Detail |
0.080 | Carcinogenesis | These results indicate that RD deletion and BMI1 overexpression frequently occur... | BeFree | 24302590 | Detail |
0.080 | Carcinogenesis | Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis. | BeFree | 24910389 | Detail |
0.080 | Carcinogenesis | Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic... | BeFree | 25029561 | Detail |
0.080 | Carcinogenesis | Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis. | BeFree | 25138050 | Detail |
0.080 | Carcinogenesis | p16(INK4a) is a tumor suppressor gene, frequently hypermethylated in breast canc... | BeFree | 25344837 | Detail |
0.080 | Carcinogenesis | There is a need for identification of biomarkers to identify people at risk of e... | BeFree | 25361631 | Detail |
0.080 | Carcinogenesis | The aim of this study was to investigate promoter methylation of certain tumor s... | BeFree | 25417611 | Detail |
0.080 | Carcinogenesis | We hypothesize that the presence of the fourth product, pALT(INK4a/b) of the INK... | BeFree | 25550505 | Detail |
0.080 | Carcinogenesis | We have shown that an epigenetic diet can influence both cellular longevity and ... | BeFree | 25568452 | Detail |
0.080 | Carcinogenesis | Regarding the oncogenesis of primary brain tumors, it was shown that changes in ... | BeFree | 26124340 | Detail |
<0.001 | Chemical Carcinogenesis | NA | BeFree | Detail | |
<0.001 | Biliary stricture | NA | BeFree | Detail | |
0.004 | Leukemogenesis | NA | BeFree | Detail | |
<0.001 | Lymphoid neoplasm | NA | BeFree | Detail | |
<0.001 | Infective cystitis | NA | BeFree | Detail | |
0.006 | prostate carcinoma | Association of increased levels of TGF-β1 and p14ARF in prostate carcinoma cell ... | BeFree | 25224321 | Detail |
0.006 | prostate carcinoma | Association of p16 gene methylation with prostate cancer risk: a meta-analysis. | BeFree | 26416059 | Detail |
0.002 | hepatopulmonary syndrome | NA | GAD | Detail | |
0.002 | CARCINOMA OF VULVA | However, our data support the presence of 2 different mechanisms for p16INK4A ex... | BeFree | 25605180 | Detail |
<0.001 | Gastro-esophageal reflux disease with esophagitis | NA | BeFree | Detail | |
<0.001 | Hereditary Breast and Ovarian Cancer Syndrome | NA | BeFree | Detail | |
0.120 | Brain Stem Neoplasms | NA | CTD_human | Detail | |
0.006 | Epithelial ovarian cancer | p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma ... | BeFree,GAD | 25972325 | Detail |
0.002 | invasive cancer | NA | BeFree | Detail | |
<0.001 | Progressive Neoplastic Disease | NA | BeFree | Detail | |
<0.001 | Locally Advanced Malignant Neoplasm | Six genes were differentially expressed in patients with localized and locally a... | BeFree | 26408707 | Detail |
0.023 | breast carcinoma | In a cross-sectional study of 138 women with no history of breast cancer who und... | BeFree | 25344837 | Detail |
<0.001 | Lesion of stomach | NA | BeFree | Detail | |
0.030 | Carcinoma of lung | Furthermore, comparative analysis of mutant Kras;Cdkn2a null with Kras;Cdkn2ab n... | BeFree,GAD | 24618618 | Detail |
0.030 | Carcinoma of lung | A cross-sectional study was conducted in which the methylation status of DAPK, C... | BeFree,GAD | 25069886 | Detail |
0.030 | Carcinoma of lung | In the present study, the diagnostic utility of the SHOX2 assay was tested with ... | BeFree,GAD | 25331797 | Detail |
0.030 | Carcinoma of lung | ANRIL, a lncRNA co-clustered mainly with p14/ARF has been reported to be dysregu... | BeFree,GAD | 25966845 | Detail |
<0.001 | Ewings sarcoma-primitive neuroectodermal tumor (PNET) | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
0.010 | Secondary malignant neoplasm of lymph node | Patients with a lower alcohol consumption, only level II/III metastasis, and cys... | BeFree | 24993345 | Detail |
0.010 | Secondary malignant neoplasm of lymph node | The results showed that the membrane weighted index of β-catenin was inversely c... | BeFree | 25209444 | Detail |
0.010 | Secondary malignant neoplasm of lymph node | Thus, patients with P16(ink4a) negative penile cancer, particularly those with l... | BeFree | 25261804 | Detail |
0.010 | Secondary malignant neoplasm of lymph node | Moreover, p16 protein was associated with CIN grade and lymph node metastases in... | BeFree | 25910412 | Detail |
<0.001 | extranodal lymphoma | NA | BeFree | Detail | |
0.005 | colon carcinoma | Molecular subtypes in stage II-III colon cancer defined by genomic instability: ... | BeFree | 25879218 | Detail |
0.017 | stomach carcinoma | Cell-cycle regulation was affected by aberrant methylation of CDKN2A and CHFR in... | BeFree | 24510342 | Detail |
0.017 | stomach carcinoma | The present results indicated that the methylation of p16, CDH1, MGMT, and hMLH1... | BeFree | 24816738 | Detail |
0.017 | stomach carcinoma | The relationship between P16 gene promoter methylation and gastric cancer: a met... | BeFree | 25693938 | Detail |
0.017 | stomach carcinoma | ANRIL, a lncRNA co-clustered mainly with p14/ARF has been reported to be dysregu... | BeFree | 25966845 | Detail |
0.017 | stomach carcinoma | Moreover, their combined treatment synergistically arrested GC cells at G0/G1 ph... | BeFree | 26173505 | Detail |
0.015 | Carcinoma of bladder | Detection of human papillomavirus infection and p16 immunohistochemistry express... | BeFree | 24675970 | Detail |
0.015 | Carcinoma of bladder | Transfection of the DNAzyme caused significant down-regulation of DNMT1 expressi... | BeFree | 25888794 | Detail |
0.002 | skin carcinoma | NA | BeFree | Detail | |
0.006 | Central neuroblastoma | NA | BeFree | Detail | |
<0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
<0.001 | bile duct carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
<0.001 | anal cancer squamous cell | Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell An... | BeFree | 26530750 | Detail |
<0.001 | Poorly differentiated carcinoma | NA | BeFree | Detail | |
<0.001 | cervical cancer squamous cell | NA | BeFree | Detail | |
<0.001 | gastritis h pylori | NA | BeFree | Detail | |
<0.001 | biliary tract cancer | NA | BeFree | Detail | |
<0.001 | Brain Tumor, Primary | Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G P... | BeFree | 26124340 | Detail |
<0.001 | Primary malignant neoplasm of brain | NA | BeFree | Detail | |
0.004 | Well Differentiated Oligodendroglioma | After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly as... | BeFree | 25853694 | Detail |
<0.001 | Malignant neoplasm tonsil | NA | BeFree | Detail | |
0.002 | adult acute lymphocytic leukemia | The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adul... | BeFree | 25675863 | Detail |
<0.001 | Basal Cell Cancer | NA | BeFree | Detail | |
0.004 | Malignant Squamous Cell Neoplasm | The p14 promoter was unmethylated in 86.7 % of OSCC and in 85.7 % of LSCC patien... | BeFree | 24710824 | Detail |
0.004 | Malignant Squamous Cell Neoplasm | Development of squamous cell cancer of head and neck (SCCHN) is associated with ... | BeFree | 25640361 | Detail |
0.005 | malignant peripheral nerve sheath tumor | Genetic inactivation of PRC2 components, NF1, and CDKN2A are frequently detected... | BeFree | 25367955 | Detail |
<0.001 | Chromosome 10, monosomy 10q | NA | BeFree | Detail | |
0.004 | malignant pleural mesothelioma | MDM2 is an important prognostic and predictive factor for platin-pemetrexed ther... | BeFree | 25668009 | Detail |
<0.001 | psychological distress | NA | BeFree | Detail | |
<0.001 | Spots on skin | Polysomy 6 and p16 deletion were significantly more frequent in noninvasive than... | BeFree | 25517961 | Detail |
0.002 | Helicobacter pylori infection | NA | BeFree | Detail | |
0.002 | Carcinoma in situ of uterine cervix | NA | BeFree | Detail | |
<0.001 | Arteriopathic disease | NA | BeFree | Detail | |
<0.001 | penis carcinoma | Thus, patients with P16(ink4a) negative penile cancer, particularly those with l... | BeFree | 25261804 | Detail |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
<0.001 | Pineal germinoma | NA | BeFree | Detail | |
<0.001 | Carcinogenicity | NA | BeFree | Detail | |
<0.001 | Pancreatic adenocarcinoma metastatic | NA | BeFree | Detail | |
<0.001 | Mycosis fungoides/Sezary syndrome NOS | NA | BeFree | Detail | |
<0.001 | Borderline ovarian tumour | NA | BeFree | Detail | |
<0.001 | dedifferentiated chondrosarcoma | NA | BeFree | Detail | |
<0.001 | Ewing's tumour localised | Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in... | BeFree | 25464386 | Detail |
<0.001 | Hyperkeratosis | NA | BeFree | Detail | |
0.003 | Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | Gastric hyperplastic polyp | NA | BeFree | Detail | |
0.123 | Carcinoma, Pancreatic Ductal | NA | BeFree,CTD_human,GAD | Detail | |
0.020 | ovarian neoplasm | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Metastatic Prostate Carcinoma | NA | BeFree | Detail | |
0.003 | precancerous lesions | NA | BeFree | Detail | |
<0.001 | Ischemic stroke | NA | BeFree | Detail | |
<0.001 | salivary gland carcinoma | NA | BeFree | Detail | |
<0.001 | Polyomavirus Infections | NA | BeFree | Detail | |
0.003 | Papillomavirus Infections | NA | BeFree,LHGDN | Detail | |
<0.001 | Plasma cell dyscrasia | NA | BeFree | Detail | |
0.021 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
0.140 | Squamous cell carcinoma of the head and neck | Alterations in RD(INK4/ARF) -mediated en bloc regulation of the INK4-ARF locus i... | BeFree,CTD_human | 24302590 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | KRAS-variant genotyping was conducted for these samples and 8 HNSCC cell lines. ... | BeFree,CTD_human | 25081901 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | North-American survey on HPV-DNA and p16 testing for head and neck squamous cell... | BeFree,CTD_human | 25096827 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | All HPV oncogene-expressing HNSCC showed p16(INK4a) /Ki-67 co-expression. | BeFree,CTD_human | 25104331 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | In conclusion, the data emphasize the urge for further data on HPV-infection in ... | BeFree,CTD_human | 25310104 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | A simultaneous immunocytochemical detection of p16(INK4a) and Ki67 can reliably ... | BeFree,CTD_human | 25557267 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic... | BeFree,CTD_human | 25575976 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | To evaluate the impact of p16INK4a (p16) expression on clinical efficacy of indu... | BeFree,CTD_human | 25810339 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | Human papillomavirus (HPV), p16 expression, and TP53 mutations are known prognos... | BeFree,CTD_human | 25871546 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | Among those HNSCCs that were positive for HR-HPV, 18 (100%) of 18 originated fro... | BeFree,CTD_human | 25873503 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | These results suggest that UGT2B17-deletion interacting with p16 (+) may modify ... | BeFree,CTD_human | 25886176 | Detail |
0.140 | Squamous cell carcinoma of the head and neck | Human papillomavirus E7 serology and association with p16 immunohistochemistry i... | BeFree,CTD_human | 26116154 | Detail |
<0.001 | Ductal Carcinoma | NA | BeFree | Detail | |
0.002 | Chromosomal Instability | NA | GAD | Detail | |
0.002 | Glucose Metabolism Disorders | NA | GAD | Detail | |
0.008 | sarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Persistent infection | NA | BeFree | Detail | |
<0.001 | large cell neuroendocrine carcinoma | NA | BeFree | Detail | |
<0.001 | basaloid squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Traditional Serrated Adenoma | However, CDKN2A (encoding the p16 protein) is silenced nearly exclusively in the... | BeFree | 25216220 | Detail |
<0.001 | metanephric adenoma | NA | BeFree | Detail | |
<0.001 | Solitary fibrous tumor | NA | BeFree | Detail | |
<0.001 | Intracortical osteosarcoma | NA | BeFree | Detail | |
<0.001 | major depressive disorder | NA | BeFree | Detail | |
<0.001 | Primary cutaneous B-cell lymphoma | NA | BeFree | Detail | |
<0.001 | Familial multiple trichoepitheliomata | NA | BeFree | Detail | |
<0.001 | Avellino corneal dystrophy | These accumulations were associated with decreased levels of Cyclin A1, B1, and ... | BeFree | 25450621 | Detail |
<0.001 | Chronic leukemia (category) | NA | BeFree | Detail | |
<0.001 | Primary Effusion Lymphoma | NA | BeFree | Detail | |
0.003 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | Chronic myeloproliferative disorder | Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter ... | BeFree | 25236537 | Detail |
<0.001 | Therapy-related myelodysplastic syndrome | NA | BeFree | Detail | |
<0.001 | Single tumor | NA | BeFree | Detail | |
<0.001 | Pancreatic intraepithelial neoplasia | NA | BeFree | Detail | |
<0.001 | Salivary duct carcinoma | NA | BeFree | Detail | |
<0.001 | blastic plasmacytoid dendritic cell neoplasm | NA | BeFree | Detail | |
0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
<0.001 | Melanocytic neoplasm | Cdkn2a loss is associated with mTORC2 and Akt activation in human and murine mel... | BeFree | 25584893 | Detail |
0.007 | Low Grade Squamous Intraepithelial Neoplasia | Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypi... | BeFree | 24744261 | Detail |
0.007 | Low Grade Squamous Intraepithelial Neoplasia | HPV DNA genotyping and methylation of gene p16 INK4A in cervical LSIL. | BeFree | 25579180 | Detail |
<0.001 | ACTH-secreting pituitary adenoma | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
<0.001 | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | NA | BeFree | Detail | |
<0.001 | Atypical Ductal Breast Hyperplasia | NA | BeFree | Detail | |
<0.001 | Brain Stem Astrocytoma | NA | BeFree | Detail | |
<0.001 | Cervical Squamous Intraepithelial Neoplasia | NA | BeFree | Detail | |
0.001 | Hereditary Malignant Neoplasm | In specific PC populations, including in Italy, hereditary cancer predisposition... | BeFree | 25152581 | Detail |
<0.001 | Flat Ductal Epithelial Atypia of the Breast | NA | BeFree | Detail | |
<0.001 | Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | NA | BeFree | Detail | |
<0.001 | Hepatitis B Virus-Related Hepatocellular Carcinoma | NA | BeFree | Detail | |
<0.001 | Hereditary Nonpolyposis Colorectal Cancer | NA | BeFree | Detail | |
<0.001 | Hereditary Non-Polyposis Colon Cancer Type 2 | NA | BeFree | Detail | |
0.003 | High Grade Cervical Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | High Grade Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | indolent lymphoma | NA | BeFree | Detail | |
<0.001 | Infiltrating Cervical Carcinoma | NA | BeFree | Detail | |
0.002 | Invasive Carcinoma | Copy number and loss of heterogeneity (LOH) profiles were similar in all six car... | BeFree | 25502898 | Detail |
<0.001 | Large Cell Lung Neuroendocrine Carcinoma | NA | BeFree | Detail | |
<0.001 | Mucinous Neoplasm | NA | BeFree | Detail | |
<0.001 | Opisthorchis Viverrini-Related Cholangiocarcinoma | NA | BeFree | Detail | |
<0.001 | optic nerve astrocytoma | NA | BeFree | Detail | |
0.004 | pancreatic ductal adenocarcinoma | Loss of the CDK4/6 inhibitor CDKN2A is a signature genetic event in PDA. | BeFree | 25156567 | Detail |
<0.001 | Conventional Chondrosarcoma | Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in... | BeFree | 25432631 | Detail |
<0.001 | Primary Carcinoma | NA | BeFree | Detail | |
<0.001 | Vulvar Intraepithelial Neoplasia, Differentiated Type | NA | BeFree | Detail | |
<0.001 | Sporadic Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma of urinary bladder, superficial | NA | BeFree | Detail | |
<0.001 | supratentorial primitive neuroectodermal tumor | NA | BeFree | Detail | |
<0.001 | Well Differentiated Pancreatic Endocrine Tumor | Deletions of RDINK4/ARF enhancer in gastrinomas and nonfunctioning pancreatic ne... | BeFree | 25003221 | Detail |
<0.001 | differentiated thyroid gland carcinoma | NA | BeFree | Detail | |
<0.001 | Hypopharyngeal Carcinoma | NA | BeFree | Detail | |
0.001 | Epithelioma | NA | BeFree | Detail | |
<0.001 | Pleural Mesothelioma | NA | BeFree | Detail | |
0.001 | renal carcinoma | NA | BeFree | Detail | |
<0.001 | Metastatic Carcinoma | NA | BeFree | Detail | |
<0.001 | Primary Lesion | In total, 24% of the HNSCCUP patients were p16 positive. p16 overexpression in n... | BeFree | 24993345 | Detail |
<0.001 | Primary Lesion | Germline CDKN2A mutations affecting p16(INK4a) were detected in 8 unrelated prob... | BeFree | 25023876 | Detail |
<0.001 | anal squamous cell carcinoma | By contrast, p16 negatively, but not HPV 16 genotype, is an independent adverse ... | BeFree | 25702585 | Detail |
<0.001 | Chronic esophagitis | NA | BeFree | Detail | |
<0.001 | Cardiomyopathy, Familial Idiopathic | NA | BeFree | Detail | |
0.120 | Micronuclei, Chromosome-Defective | NA | CTD_human | Detail | |
0.002 | Benign melanocytic nevus | NA | BeFree | Detail | |
0.158 | Mammary Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | Angiogenic Switch | NA | BeFree | Detail | |
0.006 | Hepatocarcinogenesis | NA | BeFree | Detail | |
0.145 | Hereditary Melanoma | Germline mutations in the tumour suppressor gene CDKN2A occur in 5-20% of famili... | BeFree,CLINVAR,GAD | 24935963 | Detail |
0.145 | Hereditary Melanoma | Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma... | BeFree,CLINVAR,GAD | 25023876 | Detail |
0.145 | Hereditary Melanoma | Genetics of familial melanoma: 20 years after CDKN2A. | BeFree,CLINVAR,GAD | 25431349 | Detail |
0.145 | Hereditary Melanoma | Familial melanomas with CDKN2A mutations preferentially express a histologic phe... | BeFree,CLINVAR,GAD | 25592620 | Detail |
0.001 | Cervical high grade squamous intraepithelial lesion | NA | BeFree | Detail | |
<0.001 | Mammary Tumorigenesis | NA | BeFree | Detail | |
<0.001 | Primary Glioblastoma | NA | BeFree | Detail | |
<0.001 | cholangiolocellular carcinoma | A borderline between cholangiolocellular carcinoma and the surrounding ductular ... | BeFree | 25289642 | Detail |
<0.001 | Low Grade Cervical Squamous Intraepithelial Neoplasia | NA | BeFree | Detail | |
<0.001 | Malignant Conversion | NA | BeFree | Detail | |
<0.001 | ovarian clear cell adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Secondary Glioblastoma | NA | BeFree | Detail | |
<0.001 | Skin Carcinogenesis | NA | BeFree | Detail | |
<0.001 | Xenograft Model | Our results show that the clinical candidate AKT inhibitor MK-2206 promotes ARF ... | BeFree | 25071014 | Detail |
0.036 | colorectal cancer | Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL... | BeFree,GAD | 25015728 | Detail |
0.036 | colorectal cancer | Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation wit... | BeFree,GAD | 25576161 | Detail |
0.036 | colorectal cancer | An adenoviral construct of the human p14ARF gene (a tumor suppressor) and a 22 a... | BeFree,GAD | 25935465 | Detail |
<0.001 | Ductal Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Neoplasms, Intracranial | NA | BeFree | Detail | |
<0.001 | smoldering myeloma | NA | BeFree | Detail | |
0.001 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | NA | BeFree | Detail | |
<0.001 | Non-Malignant Ascites Adverse Event | NA | BeFree | Detail | |
0.001 | Adenocarcinoma, Endometrioid | ECCCs had SCA-like features with rare expression of estrogen receptor/progestero... | BeFree | 25473756 | Detail |
0.002 | Glioblastoma multiforme | NA | BeFree | Detail | |
0.002 | Cirrhosis | NA | BeFree | Detail | |
<0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
<0.001 | Enchondroma | NA | BeFree | Detail | |
<0.001 | Colorectal Mucinous Adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Colorectal Signet Ring Cell Carcinoma | NA | BeFree | Detail | |
<0.001 | Invasive Skin Melanoma | Biallelic inactivation of CDKN2A emerged exclusively in invasive melanomas. | BeFree | 26559571 | Detail |
0.004 | Non-Neoplastic Disorder | Polysomy 6 and p16 deletion were significantly more frequent in noninvasive than... | BeFree | 25517961 | Detail |
<0.001 | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | NA | BeFree | Detail | |
<0.001 | Pyothorax-Associated Lymphoma | NA | BeFree | Detail | |
0.002 | Meningioma, benign, no ICD-O subtype | Progression to a clinically aggressive meningioma is linked to inactivation of C... | BeFree | 25993161 | Detail |
0.003 | Idiopathic Pulmonary Fibrosis | NA | BeFree,LHGDN | Detail | |
0.361 | Melanoma astrocytoma syndrome | NA | BeFree,CLINVAR,CTD_human,ORPHANET | Detail | |
0.240 | MELANOMA, CUTANEOUS MALIGNANT, 2 | NA | CTD_human,UNIPROT | Detail | |
0.240 | Li-Fraumeni syndrome 1 | NA | CTD_human,UNIPROT | Detail | |
<0.001 | SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder) | NA | BeFree | Detail | |
0.080 | Oculopalatocerebral Syndrome | NA | MGD | Detail | |
<0.001 | Familial primary gastric lymphoma | NA | BeFree | Detail | |
<0.001 | lateral meningocele syndrome | NA | BeFree | Detail | |
<0.001 | ulnar-mammary syndrome | NA | BeFree | Detail | |
<0.001 | Retinomas (translucent, grayish retinal mass protruding into the vitreous) | NA | BeFree | Detail | |
<0.001 | B-CELL MALIGNANCY, LOW-GRADE | NA | BeFree | Detail | |
<0.001 | biliary papillomatosis | NA | BeFree | Detail | |
<0.001 | Inverted Squamous Cell Papilloma | NA | BeFree | Detail | |
0.002 | uterine corpus cancer | NA | BeFree | Detail | |
<0.001 | Wolf-Hirschhorn syndrome | NA | BeFree | Detail | |
0.012 | coronary artery disease | Using this approach, numerous studies have associated SNPs on chromosome 9p21.3 ... | BeFree,GAD | 25744911 | Detail |
0.009 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree,LHGDN | Detail | |
0.275 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Deletions of EBF1, IKZF1, and CDKN2A/B have an independent adverse prognosis for... | BeFree,CTD_human,GAD,GWASCAT,LHGDN | 26194343 | Detail |
<0.001 | low grade glioma | NA | BeFree | Detail | |
<0.001 | Autosomal aneuploidy | NA | BeFree | Detail | |
0.002 | Urothelial Carcinoma | To determine the potential association between HPV infection and the squamous ce... | BeFree | 24675970 | Detail |
<0.001 | eyelids (symptom) | Furthermore, p16 overexpression in eyelid SCs was also significantly higher than... | BeFree | 25468813 | Detail |
0.252 | liver carcinoma | Role of P14 and MGMT gene methylation in hepatocellular carcinomas: a meta-analy... | BeFree,CTD_human,LHGDN,RGD | 25169493 | Detail |
0.252 | liver carcinoma | Sirtuin 6 in turn abrogated the inducing effect of TGF-β1/H2O2/HOCl on cellular ... | BeFree,CTD_human,LHGDN,RGD | 25683165 | Detail |
0.252 | liver carcinoma | During the last 10 years, there has been a clear delineation of the landscape of... | BeFree,CTD_human,LHGDN,RGD | 26099527 | Detail |
0.003 | Familial Atypical Mole Melanoma Syndrome | The p16-Leiden founder mutation in the CDKN2A gene is the most common cause of F... | BeFree | 26111702 | Detail |
<0.001 | Triple-negative breast carcinoma | NA | BeFree | Detail | |
0.006 | Oropharyngeal Carcinoma | The majority of North American respondents in this survey systematically test fo... | BeFree | 25096827 | Detail |
0.006 | Oropharyngeal Carcinoma | Interestingly, the prognostic significance of p16 overexpression is different fr... | BeFree | 25339028 | Detail |
0.006 | Oropharyngeal Carcinoma | Among these biomarkers, p53 is the strongest prognostic marker in OPC and p53 in... | BeFree | 25380690 | Detail |
0.006 | Oropharyngeal Carcinoma | Significant correlations were confirmed between p16 positivity and oropharyngeal... | BeFree | 25503184 | Detail |
0.006 | Oropharyngeal Carcinoma | Overall, this study provides evidence of epigenetic changes to the downstream re... | BeFree | 25619363 | Detail |
0.006 | Oropharyngeal Carcinoma | Prognostic value of p16 expression irrespective of human papillomavirus status i... | BeFree | 26056326 | Detail |
0.006 | Oropharyngeal Carcinoma | Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southea... | BeFree | 26152733 | Detail |
<0.001 | Cerebral Small Vessel Diseases | NA | BeFree | Detail | |
<0.001 | Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma | The results showed that the membrane weighted index of β-catenin was inversely c... | BeFree | 25209444 | Detail |
<0.001 | Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma | Epigenetic changes in the CDKN2A locus are associated with differential expressi... | BeFree | 25619363 | Detail |
<0.001 | Chronic ulcerative colitis | NA | BeFree | Detail | |
0.123 | Pancreatic carcinoma, familial | NA | BeFree,ORPHANET | Detail | |
<0.001 | Atypical Hemolytic Uremic Syndrome | Genomic aberrations affecting the genes encoding factor H (FH) and the five FH-r... | BeFree | 24904082 | Detail |
0.126 | Nasopharyngeal carcinoma | We here evaluated p16 INK4A as a prognostic marker of treatment response and sur... | BeFree,CTD_human | 25640361 | Detail |
<0.001 | Cervix Intraepithelial Neoplasia Grade 3 AJCC v7 | NA | BeFree | Detail | |
0.002 | Solar Erythema | NA | GAD | Detail | |
<0.001 | Condylomatous carcinoma | Diffuse p16 expression was associated with younger age at presentation (P<0.0001... | BeFree | 26171917 | Detail |
<0.001 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
<0.001 | Biliary System Disorder | NA | BeFree | Detail | |
0.003 | myelodysplastic syndrome | NA | BeFree,GAD | Detail | |
<0.001 | plasmablastic lymphoma | NA | BeFree | Detail | |
<0.001 | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | NA | BeFree | Detail | |
<0.001 | Progressive cGVHD | NA | BeFree | Detail | |
<0.001 | Triple Negative Breast Neoplasms | NA | BeFree | Detail | |
0.001 | Melanocytic nevus of skin | NA | BeFree | Detail | |
<0.001 | Mammary adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Proliferative verrucous oral leukoplakia | NA | BeFree | Detail | |
0.014 | Infection | NA | LHGDN | Detail | |
0.120 | Leukemia, acute lymphoblastic, susceptibility to, 3 | NA | ORPHANET | Detail | |
0.003 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
<0.001 | High grade serous carcinoma | Immunohistochemistry (IHC) was used to examine STMN1 and p16 expression in fallo... | BeFree | 26206555 | Detail |
<0.001 | Cytogenetically normal acute myeloid leukemia | NA | BeFree | Detail | |
0.180 | adenocarcinoma | Different roles for p16(INK) (4a) -Rb pathway and INK4a/ARF methylation between ... | BeFree,CTD_human,GAD,LHGDN | 25123601 | Detail |
0.021 | adenoma | NA | BeFree,LHGDN | Detail | |
0.120 | Adrenal Gland Neoplasms | NA | CTD_human | Detail | |
<0.001 | Primary myelofibrosis | NA | BeFree | Detail | |
0.003 | Alzheimer's disease | NA | BeFree,GAD | Detail | |
<0.001 | ameloblastoma | NA | BeFree | Detail | |
<0.001 | amyotrophic lateral sclerosis | NA | BeFree | Detail | |
0.001 | Anaplasia | NA | BeFree | Detail | |
<0.001 | anemia | NA | BeFree | Detail | |
0.002 | Aneuploidy | NA | GAD | Detail | |
<0.001 | Anxiety Disorders | NA | BeFree | Detail | |
<0.001 | aortic aneurysm | NA | BeFree | Detail | |
0.002 | arteriosclerosis | An increased CDKN2A gene expression in carotid plaques may increase the severity... | BeFree | 24599170 | Detail |
<0.001 | arthritis | NA | BeFree | Detail | |
<0.001 | Arthritis, Adjuvant-Induced | NA | BeFree | Detail | |
0.002 | rheumatoid arthritis | NA | BeFree | Detail | |
0.002 | asthma | NA | GAD | Detail | |
0.015 | Astrocytoma | Herein we showed that activation of CD47 in human astrocytoma cell lines U87 and... | BeFree,LHGDN | 25550546 | Detail |
0.015 | Astrocytoma | CDKN2A loss is associated with shortened overall survival in lower-grade (World ... | BeFree,LHGDN | 25853694 | Detail |
<0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
0.004 | atherosclerosis | An increased CDKN2A gene expression in carotid plaques may increase the severity... | BeFree,GAD | 24599170 | Detail |
<0.001 | Tooth Attrition | NA | BeFree | Detail | |
<0.001 | Autoimmune Diseases | NA | BeFree | Detail | |
0.011 | Barrett esophagus | Barrett's esophagus is thought to progress to esophageal adenocarcinoma (EAC) th... | BeFree,GAD,LHGDN | 26192918 | Detail |
<0.001 | Behcet Syndrome | NA | BeFree | Detail | |
0.002 | Bile Duct Neoplasms | NA | GAD | Detail | |
0.022 | Malignant neoplasm of urinary bladder | Detection of human papillomavirus infection and p16 immunohistochemistry express... | BeFree,GAD | 24675970 | Detail |
0.022 | Malignant neoplasm of urinary bladder | Transfection of the DNAzyme caused significant down-regulation of DNMT1 expressi... | BeFree,GAD | 25888794 | Detail |
0.145 | Bladder Neoplasm | NA | BeFree,CTD_human,LHGDN | Detail | |
0.002 | Blast Phase | NA | BeFree | Detail | |
0.136 | Brain Neoplasms | NA | BeFree,CTD_human,GAD | Detail | |
<0.001 | Branchioma | However, cases of ambiguous p16(INK4a) overexpression are regularly detected in ... | BeFree | 25104331 | Detail |
0.043 | Malignant neoplasm of breast | In a cross-sectional study of 138 women with no history of breast cancer who und... | BeFree,GAD | 25344837 | Detail |
<0.001 | Brenner Tumor | NA | BeFree | Detail | |
0.002 | Burkitt lymphoma | Quantitative analysis of CDKN2A methylation, mRNA, and p16(INK4a) protein expres... | BeFree | 25542698 | Detail |
0.002 | calcinosis | NA | GAD | Detail | |
<0.001 | Carcinoid Tumor | NA | BeFree | Detail | |
0.005 | Malignant tumor of colon | Molecular subtypes in stage II-III colon cancer defined by genomic instability: ... | BeFree | 25879218 | Detail |
0.002 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
<0.001 | female breast carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of larynx | NA | BeFree | Detail | |
<0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of skin | Vitamin C protects against UV irradiation-induced apoptosis through reactivating... | BeFree | 25003799 | Detail |
0.002 | Malignant neoplasm of skin | CDKN2a mutation-negative melanoma families have increased risk exclusively for s... | BeFree | 25943250 | Detail |
0.002 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
0.008 | basal cell carcinoma | NA | GAD,LHGDN | Detail | |
0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
0.001 | Merkel cell carcinoma | NA | BeFree | Detail | |
<0.001 | mucinous adenocarcinoma | NA | BeFree | Detail | |
0.150 | Non-small cell lung carcinoma | Assessment of the prognostic value of methylation status and expression levels o... | BeFree,CTD_human,GAD | 24935385 | Detail |
0.150 | Non-small cell lung carcinoma | Methylation of APC and/or p16 was related to advanced staging in non-small cell ... | BeFree,CTD_human,GAD | 26119430 | Detail |
0.004 | Carcinoma, Papillary | NA | BeFree,LHGDN | Detail | |
0.014 | renal cell carcinoma | NA | BeFree,LHGDN | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
In a phase 2 trial, patients with pancreatic cancer with CDKN2A loss or mutation were received palbo... | CIViC Evidence | Detail |
In a phase 2 trial, patients with gallbladder cancer or bile duct cancer with CDKN2A loss or mutatio... | CIViC Evidence | Detail |
The p14 promoter was unmethylated in 86.7 % of OSCC and in 85.7 % of LSCC patients; for the p16 prom... | DisGeNET | Detail |
The correlation between p16 expression and INK4a locus mutation with grades and stages in oral squam... | DisGeNET | Detail |
HPV infection appears to be involved in cancer progression in SQC by promoting the expression of p53... | DisGeNET | Detail |
p16INK4A expression in squamous cell carcinomas of the vagina and the vulva in Tunisian women. | DisGeNET | Detail |
Development of squamous cell cancer of head and neck (SCCHN) is associated with human papillomavirus... | DisGeNET | Detail |
Human papillomavirus (HPV), p16 expression, and TP53 mutations are known prognostic factors in head ... | DisGeNET | Detail |
These findings utilize morphologic and immunohistochemical analysis to support HPV-associated and HP... | DisGeNET | Detail |
To determine the potential association between HPV infection and the squamous cell component of urot... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Transcriptome analysis of mouse and human DCM samples indicates that p16(INK4a) derepression, accomp... | DisGeNET | Detail |
NA | DisGeNET | Detail |
A dense infiltrate of IL-6(+) mononuclear cells was detected in active coeliac disease, also localis... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Medline, Embase and China National Knowledge Infrastructures were searched to identify studies on th... | DisGeNET | Detail |
Methylation of the p16(INK4a) gene occurs early in the development of cervical cancer. | DisGeNET | Detail |
p16INK4A expression could be used as a useful marker for HPV positivity in vaginal SCCs similar to t... | DisGeNET | Detail |
Moreover, p16 protein was associated with CIN grade and lymph node metastases in cervical cancer (al... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunohistochemistry of p16INK4A staining shows nil (0/25) expression in the cervicitis patients, 72... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In contrast, the expression of p16INK4a was seen in most bile duct adenomas and all ductular reactio... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We show that p16/CDKN2A copy number variation occurs subsequent to the IDH1 mutation, and confirm th... | DisGeNET | Detail |
Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Progression from ulcerative colitis (UC) toward colorectal carcinoma (CRC) is multistep process that... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorab... | DisGeNET | Detail |
Progression from ulcerative colitis (UC) toward colorectal carcinoma (CRC) is multistep process that... | DisGeNET | Detail |
Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis i... | DisGeNET | Detail |
An adenoviral construct of the human p14ARF gene (a tumor suppressor) and a 22 amino acid sequence o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We review the current knowledge, from studies using human and mouse models, describing the function ... | DisGeNET | Detail |
We review the current knowledge, from studies using human and mouse models, describing the function ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Therefore, we hypothesized that the genetic variants in these three genes influence the predispositi... | DisGeNET | Detail |
Therefore, we hypothesized that the genetic variants in these three genes influence the predispositi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Thus, p16 hypermethylation may aid as a biomarker in identifying habitués at greater risk for esopha... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Polysomy 6 and p16 deletion were significantly more frequent in noninvasive than in non-neoplastic s... | DisGeNET | Detail |
Furthermore, p16 overexpression in eyelid SCs was also significantly higher than that in other eyeli... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Deletions of RDINK4/ARF enhancer in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Finally, the G-CIMP+ Ink4a-Arf-/- EGFRvIII glioblastoma line was more resistant to the EGFR inhibito... | DisGeNET | Detail |
CD47 activation-induced UHRF1 over-expression is associated with silencing of tumor suppressor gene ... | DisGeNET | Detail |
Bmi-1 regulates the migration and invasion of glioma cells through p16. | DisGeNET | Detail |
BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-... | DisGeNET | Detail |
These findings suggest that CDKN2A testing may provide further clinical aid in lower-grade glioma su... | DisGeNET | Detail |
CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma. | DisGeNET | Detail |
These findings show that CDKN2 p16 540 C>G, CDKN2 p16 580 C>T and MDM2 SNP309 T>G variants and their... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ECCCs had SCA-like features with rare expression of estrogen receptor/progesterone receptor (18.8%/6... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Interestingly, all the aggressive cases did not express p16(INK4a), thus suggesting that loss of sen... | DisGeNET | Detail |
Peptides (9mer to 11mer) were designed based on HLA-I-binding algorithms for B*27, B*57, or B*5801 (... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Deletions of EBF1, IKZF1, and CDKN2A/B have an independent adverse prognosis for adolescents and adu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cell-cycle regulation was affected by aberrant methylation of CDKN2A and CHFR in 13 GCs. | DisGeNET | Detail |
The present results indicated that the methylation of p16, CDH1, MGMT, and hMLH1 was both frequent a... | DisGeNET | Detail |
The relationship between P16 gene promoter methylation and gastric cancer: a meta-analysis based on ... | DisGeNET | Detail |
ANRIL, a lncRNA co-clustered mainly with p14/ARF has been reported to be dysregulated in gastric can... | DisGeNET | Detail |
Moreover, their combined treatment synergistically arrested GC cells at G0/G1 phase, down-regulated ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Progression to a clinically aggressive meningioma is linked to inactivation of CDKN2A/B genes, and a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we lear... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The cyclin-dependent kinase inhibitor 1 (CDKN2B or p15(INK4B) ) gene lies adjacent to the tumor supp... | DisGeNET | Detail |
NA | DisGeNET | Detail |
As p16 (CDKN2A), a marker of HPV infections, was up-regulated in MG-T, we thus screened DNA from thy... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferativ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Alcohol consumption, location, and features of neck metastasis were correlated with p16 expression. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly associated with poorer... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Further, we could deduce genes with possible prognostic significance in OS for further investigation... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
None of the cell lines showed strong immunopositivity of p16 or presence of human papilloma virus. | DisGeNET | Detail |
Immunohistochemical staining provided diagnostic results for all of the examined tissue samples, and... | DisGeNET | Detail |
Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are usef... | DisGeNET | Detail |
Another significant finding was a very poor concordance between p16 expression and HPV infection sug... | DisGeNET | Detail |
Positivity for HPV DNA (44 samples, 18.9 %) and p16(INK4A) expression (102 samples, 43.8 %) were sig... | DisGeNET | Detail |
Formalin-fixed, paraffin-embedded material from each case was evaluated for p16 expression using imm... | DisGeNET | Detail |
FGFR1, -2, and -4, VEGFR2, PDGFRα, and p16 were overexpressed in primary human pheochromocytomas and... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
FGFR1, -2, and -4, VEGFR2, PDGFRα, and p16 were overexpressed in primary human pheochromocytomas and... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In the present study, the diagnostic utility of the SHOX2 assay was tested with regard to cytology f... | DisGeNET | Detail |
The aim of this study was to investigate promoter methylation of certain tumor suppressor genes, Cyc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Sequence analysis demonstrated a known deleterious mutation in CDKN2A (G-34T) and homozygosity for a... | DisGeNET | Detail |
The prime aim of this study was to evaluate the mismatch-repair (MMR)-protein deficiency and the p16... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim was to explore putative differences in p16(INK) (4a) -retinoblastoma (Rb) pathway and INK4a/... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The prime aim of this study was to evaluate the mismatch-repair (MMR)-protein deficiency and the p16... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
As p16 (CDKN2A), a marker of HPV infections, was up-regulated in MG-T, we thus screened DNA from thy... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings demonstrate that while deletions on chromosomes 4 and 11 affecting Cdkn2a and Ikaros ar... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
p19ARF is a critical mediator of both cellular senescence and an innate immune response associated w... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Correlation between squamous cell carcinoma of the lung and human papillomavirus infection and the r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This is the first estimate of the contribution of BAP1 and CDK4 to a population-based sample of CMM ... | DisGeNET | Detail |
To conclude, we propose that mutation screening of CDKN2A and CDK4 in Denmark should predominantly b... | DisGeNET | Detail |
Two-hit inactivation of CDKN2A and CDKN2B occurs frequently in patients with mutant KRAS lung adenoc... | DisGeNET | Detail |
Thus, p16 hypermethylation may aid as a biomarker in identifying habitués at greater risk for esopha... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. | DisGeNET | Detail |
NA | DisGeNET | Detail |
The majority of North American respondents in this survey systematically test for HPV-DNA and/or p16... | DisGeNET | Detail |
Interestingly, the prognostic significance of p16 overexpression is different from that reported in ... | DisGeNET | Detail |
Among these biomarkers, p53 is the strongest prognostic marker in OPC and p53 in addition to p16 sup... | DisGeNET | Detail |
Significant correlations were confirmed between p16 positivity and oropharyngeal cancer, MMP1 and p1... | DisGeNET | Detail |
Overall, this study provides evidence of epigenetic changes to the downstream region of the CDKN2A l... | DisGeNET | Detail |
Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland. | DisGeNET | Detail |
We here evaluated p16 INK4A as a prognostic marker of treatment response and survival in our SCCHN p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We evaluated combined HPV DNA and p16 status as a prognostic factor of treatment response in anal ca... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Thus, patients with P16(ink4a) negative penile cancer, particularly those with lymph node metastases... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HPV infection appears to be involved in cancer progression in SQC by promoting the expression of p53... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Copy number analyses by molecular inversion probe assays of the three spindle cell carcinoma samples... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The p16-Leiden founder mutation in the CDKN2A gene is the most common cause of Familial Atypical Mul... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Nevertheless, p16 overexpression was found in 71.4% (10/14) of SCs, irrespective of the status of HP... | DisGeNET | Detail |
NA | DisGeNET | Detail |
ECCCs had SCA-like features with rare expression of estrogen receptor/progesterone receptor (18.8%/6... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Exome and the following prevalence sequencing identified mutations of the BAP1, ARID1A, IDH1 and IDH... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
β-PV DNA was detected in 5/30 VC (16.7%) and in 18/30 normal tissue samples (60.0%): HPV-19, -24 and... | DisGeNET | Detail |
Diffuse p16 expression was associated with younger age at presentation (P<0.0001), basaloid and wart... | DisGeNET | Detail |
In this study, high-risk HPV E6/E7 and p16 mRNA expression patterns in eighty-six CIN lesions were i... | DisGeNET | Detail |
We also used immunohistochemistry (IHC) to detect the P16(INK4a) protein, the expression of which is... | DisGeNET | Detail |
Immunohistochemistry of p16INK4A staining shows nil (0/25) expression in the cervicitis patients, 72... | DisGeNET | Detail |
P16INK4A and survivin: Diagnostic and prognostic markers in cervical intraepithelial neoplasia and c... | DisGeNET | Detail |
PanHPVE4 and p16INK4a staining are complementary markers that could provide simple, reliable support... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CDKN2A/B deletions were associated with multiple MBMs and frequently hypermethylated genes with shor... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increasing knowledge about the molecular pathogenesis of the disease has shown that genetic alterati... | DisGeNET | Detail |
Our results strongly support that the deletion of RD may represent a novel mechanism to simultaneous... | DisGeNET | Detail |
Our results show that the clinical candidate AKT inhibitor MK-2206 promotes ARF nucleolar localizati... | DisGeNET | Detail |
Studies of the molecular pathology of pancreatic cancer have revealed that activation of KRAS, overe... | DisGeNET | Detail |
The p16-Leiden germline variant in the CDKN2A gene is associated with a high risk of melanoma and pa... | DisGeNET | Detail |
This review presents current evidence regarding both senescence induction and escape with respect to... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We here evaluated p16 INK4A as a prognostic marker of treatment response and survival in our SCCHN p... | DisGeNET | Detail |
Lack of P16ink4a over expression in penile squamous cell carcinoma is associated with recurrence aft... | DisGeNET | Detail |
HR-HPV(+) PSCCs overexpressed p16(INK4a) in 88% cases and p53 in 35% of cases, whereas HR-HPV(-) PSC... | DisGeNET | Detail |
The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, comparative analysis of mutant Kras;Cdkn2a null with Kras;Cdkn2ab null mice and experim... | DisGeNET | Detail |
A cross-sectional study was conducted in which the methylation status of DAPK, CDKN2A (p16) and RASS... | DisGeNET | Detail |
In the present study, the diagnostic utility of the SHOX2 assay was tested with regard to cytology f... | DisGeNET | Detail |
ANRIL, a lncRNA co-clustered mainly with p14/ARF has been reported to be dysregulated in gastric can... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
BRAF mutation and CDKN2A loss occurred early and TERT promoter mutation later in a case of lethal me... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a ... | DisGeNET | Detail |
Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive... | DisGeNET | Detail |
P16(INK4A) expression and HGAOT are independent prognostic factors for OS of patients with HNSCC, wh... | DisGeNET | Detail |
HPV-associated p16 INK4A expression and response to therapy and survival in selected head and neck c... | DisGeNET | Detail |
p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Advanced Head and Neck ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The results of this study suggested that MDM2 and p16 are predictive markers for chemoradioresistanc... | DisGeNET | Detail |
Reanalysis of additional EAC exome data showed that the majority (62.5%) of EACs emerged following g... | DisGeNET | Detail |
We evaluated combined HPV DNA and p16 status as a prognostic factor of treatment response in anal ca... | DisGeNET | Detail |
These results indicate that p16, p63 and p53 can be used as prognostic markers in gallbladder adenoc... | DisGeNET | Detail |
P16INK4A and survivin: Diagnostic and prognostic markers in cervical intraepithelial neoplasia and c... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The expression patterns of p53 and p16 and an analysis of a possible role of HPV in primary adenocar... | DisGeNET | Detail |
Changes in PTEN and CDKN2A gene sets were associated with worsened prognosis of ccRCC. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The combination of both HPV-DNA sequencing analysis and immunohistochemistry (IHC) for p16(INK4A) is... | DisGeNET | Detail |
We assessed a population-based cohort of patients diagnosed with oropharyngeal squamous cell carcino... | DisGeNET | Detail |
The authors explored the prognostic significance of heregulin/HER3 expression in patients with oroph... | DisGeNET | Detail |
We applied HPV DNA PCR and p16 immunohistochemistry to all TSCCs registered in the Danish Head and N... | DisGeNET | Detail |
P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative lar... | DisGeNET | Detail |
Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally act... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly associated with poorer... | DisGeNET | Detail |
NA | DisGeNET | Detail |
p16INK4A expression could be used as a useful marker for HPV positivity in vaginal SCCs similar to t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are usef... | DisGeNET | Detail |
Immunohistochemistry of p16INK4A staining shows nil (0/25) expression in the cervicitis patients, 72... | DisGeNET | Detail |
Medline, Embase and China National Knowledge Infrastructures were searched to identify studies on th... | DisGeNET | Detail |
Methylation of the p16(INK4a) gene occurs early in the development of cervical cancer. | DisGeNET | Detail |
p16INK4A expression could be used as a useful marker for HPV positivity in vaginal SCCs similar to t... | DisGeNET | Detail |
Moreover, p16 protein was associated with CIN grade and lymph node metastases in cervical cancer (al... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The combination TOP2A and CDKN2A/p16 has a good balance between sensitivity and specificity for the ... | DisGeNET | Detail |
A marker with high sensitivity and specificity for the detection of HSIL in cervical, vulvar, and an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Compared with CDKN2A(-) cases, mutation carriers tended to have histologic features of superficial s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Within the 1p/19q-codeleted AO, the contrast enhancement was associated with larger tumor volumes (P... | DisGeNET | Detail |
After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly associated with poorer... | DisGeNET | Detail |
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Evaluation of genetic association of the INK4 locus with primary open angle glaucoma in East Indian ... | DisGeNET | Detail |
The severity of internal carotid artery stenosis is associated with the cyclin-dependent kinase inhi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cance... | DisGeNET | Detail |
Correlation between squamous cell carcinoma of the lung and human papillomavirus infection and the r... | DisGeNET | Detail |
Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally act... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Given overexpression of a polycomb group protein EZH2 in intrahepatic cholangiocarcinoma and high ex... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Diffuse p16 expression was associated with younger age at presentation (P<0.0001), basaloid and wart... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increasing knowledge about the molecular pathogenesis of the disease has shown that genetic alterati... | DisGeNET | Detail |
Our results strongly support that the deletion of RD may represent a novel mechanism to simultaneous... | DisGeNET | Detail |
Our results show that the clinical candidate AKT inhibitor MK-2206 promotes ARF nucleolar localizati... | DisGeNET | Detail |
Studies of the molecular pathology of pancreatic cancer have revealed that activation of KRAS, overe... | DisGeNET | Detail |
The p16-Leiden germline variant in the CDKN2A gene is associated with a high risk of melanoma and pa... | DisGeNET | Detail |
This review presents current evidence regarding both senescence induction and escape with respect to... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinom... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Compared with high-risk HPV genotyping, p16(INK4a)/Ki-67 immunocytochemistry was a more accurate tri... | DisGeNET | Detail |
NA | DisGeNET | Detail |
By contrast, p16 negatively, but not HPV 16 genotype, is an independent adverse prognosticator after... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To combine clinical and molecular markers into an algorithm for predicting outcome for individual pa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of p16 gene methylation with prostate cancer risk: a meta-analysis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. | DisGeNET | Detail |
An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. | DisGeNET | Detail |
NA | DisGeNET | Detail |
The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil. | DisGeNET | Detail |
The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil. | DisGeNET | Detail |
An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. | DisGeNET | Detail |
In the total set of 189 patients we found a novel change Pro48Arg (nt 143 c > g), a novel introni... | DisGeNET | Detail |
An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. | DisGeNET | Detail |
An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. | DisGeNET | Detail |
The CDKN2A A148T variant seems to contribute to early-onset breast cancer in Poland. | DisGeNET | Detail |
The CDKN2a common variants: 148 Ala/Thr and 500 C/G in 3' UTR, and their association with clinical c... | DisGeNET | Detail |
In the total set of 189 patients we found a novel change Pro48Arg (nt 143 c > g), a novel introni... | DisGeNET | Detail |
In the total set of 189 patients we found a novel change Pro48Arg (nt 143 c > g), a novel introni... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Thus, p16 hypermethylation may aid as a biomarker in identifying habitués at greater risk for esopha... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In total, 24% of the HNSCCUP patients were p16 positive. p16 overexpression in neck metastasis was p... | DisGeNET | Detail |
No association between KRAS-variant status and p16 expression was observed in the oropharynx subset ... | DisGeNET | Detail |
Among those HNSCCs that were positive for HR-HPV, 18 (100%) of 18 originated from the oropharynx, wh... | DisGeNET | Detail |
HPV E7 seropositivity correlated with positive tumor HPV-DNA and p16 expression, and was strongly as... | DisGeNET | Detail |
Strikingly, STAG2 mutations and CDKN2A deletions were mutually exclusive, as confirmed in Ewing sarc... | DisGeNET | Detail |
A growing collection of retrospective studies have suggested that TP53 mutations and/or CDKN2A delet... | DisGeNET | Detail |
MiR-34a tumor levels significantly correlated with oropharyngeal origin (p=0.0284) and p16 positivit... | DisGeNET | Detail |
Immunohistochemistry for p16 protein is often used as a surrogate marker for oncogenic HPV in the or... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In addition, the p16(INK4a) expression is associated with carotid atherosclerosis in various patient... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Further, we could deduce genes with possible prognostic significance in OS for further investigation... | DisGeNET | Detail |
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello synd... | DisGeNET | Detail |
Our data indicate that SIX6 and/or IOP promotes POAG by directly increasing p16INK4a expression, lea... | DisGeNET | Detail |
To verify the S305N association with melanoma risk in an independent larger French population (378 p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
To verify the S305N association with melanoma risk in an independent larger French population (378 p... | DisGeNET | Detail |
To verify the S305N association with melanoma risk in an independent larger French population (378 p... | DisGeNET | Detail |
These results indicate that RD deletion and BMI1 overexpression frequently occur in the early stage ... | DisGeNET | Detail |
Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis. | DisGeNET | Detail |
Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis. | DisGeNET | Detail |
Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis. | DisGeNET | Detail |
p16(INK4a) is a tumor suppressor gene, frequently hypermethylated in breast cancer; this epigenetic ... | DisGeNET | Detail |
There is a need for identification of biomarkers to identify people at risk of esophageal cancer. p1... | DisGeNET | Detail |
The aim of this study was to investigate promoter methylation of certain tumor suppressor genes, Cyc... | DisGeNET | Detail |
We hypothesize that the presence of the fourth product, pALT(INK4a/b) of the INK4a/b locus in the na... | DisGeNET | Detail |
We have shown that an epigenetic diet can influence both cellular longevity and carcinogenesis throu... | DisGeNET | Detail |
Regarding the oncogenesis of primary brain tumors, it was shown that changes in functions of p16 and... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of increased levels of TGF-β1 and p14ARF in prostate carcinoma cell lines overexpressing... | DisGeNET | Detail |
Association of p16 gene methylation with prostate cancer risk: a meta-analysis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, our data support the presence of 2 different mechanisms for p16INK4A expression in HPV-rela... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyp... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Six genes were differentially expressed in patients with localized and locally advanced cancer (GOLM... | DisGeNET | Detail |
In a cross-sectional study of 138 women with no history of breast cancer who underwent reduction mam... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, comparative analysis of mutant Kras;Cdkn2a null with Kras;Cdkn2ab null mice and experim... | DisGeNET | Detail |
A cross-sectional study was conducted in which the methylation status of DAPK, CDKN2A (p16) and RASS... | DisGeNET | Detail |
In the present study, the diagnostic utility of the SHOX2 assay was tested with regard to cytology f... | DisGeNET | Detail |
ANRIL, a lncRNA co-clustered mainly with p14/ARF has been reported to be dysregulated in gastric can... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Patients with a lower alcohol consumption, only level II/III metastasis, and cystic lymph node metas... | DisGeNET | Detail |
The results showed that the membrane weighted index of β-catenin was inversely correlated with p16 p... | DisGeNET | Detail |
Thus, patients with P16(ink4a) negative penile cancer, particularly those with lymph node metastases... | DisGeNET | Detail |
Moreover, p16 protein was associated with CIN grade and lymph node metastases in cervical cancer (al... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-ris... | DisGeNET | Detail |
Cell-cycle regulation was affected by aberrant methylation of CDKN2A and CHFR in 13 GCs. | DisGeNET | Detail |
The present results indicated that the methylation of p16, CDH1, MGMT, and hMLH1 was both frequent a... | DisGeNET | Detail |
The relationship between P16 gene promoter methylation and gastric cancer: a meta-analysis based on ... | DisGeNET | Detail |
ANRIL, a lncRNA co-clustered mainly with p14/ARF has been reported to be dysregulated in gastric can... | DisGeNET | Detail |
Moreover, their combined treatment synergistically arrested GC cells at G0/G1 phase, down-regulated ... | DisGeNET | Detail |
Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cance... | DisGeNET | Detail |
Transfection of the DNAzyme caused significant down-regulation of DNMT1 expression and reactivation ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Pati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
After adjustment for IDH mutation, sex, and age, CDKN2A deletion was strongly associated with poorer... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblasti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The p14 promoter was unmethylated in 86.7 % of OSCC and in 85.7 % of LSCC patients; for the p16 prom... | DisGeNET | Detail |
Development of squamous cell cancer of head and neck (SCCHN) is associated with human papillomavirus... | DisGeNET | Detail |
Genetic inactivation of PRC2 components, NF1, and CDKN2A are frequently detected in MPNSTs. | DisGeNET | Detail |
NA | DisGeNET | Detail |
MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant ple... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Polysomy 6 and p16 deletion were significantly more frequent in noninvasive than in non-neoplastic s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Thus, patients with P16(ink4a) negative penile cancer, particularly those with lymph node metastases... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with local... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Alterations in RD(INK4/ARF) -mediated en bloc regulation of the INK4-ARF locus in human squamous cel... | DisGeNET | Detail |
KRAS-variant genotyping was conducted for these samples and 8 HNSCC cell lines. p16 expression was d... | DisGeNET | Detail |
North-American survey on HPV-DNA and p16 testing for head and neck squamous cell carcinoma. | DisGeNET | Detail |
All HPV oncogene-expressing HNSCC showed p16(INK4a) /Ki-67 co-expression. | DisGeNET | Detail |
In conclusion, the data emphasize the urge for further data on HPV-infection in HNSCC to, e.g. clari... | DisGeNET | Detail |
A simultaneous immunocytochemical detection of p16(INK4a) and Ki67 can reliably be performed on liqu... | DisGeNET | Detail |
High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary ... | DisGeNET | Detail |
To evaluate the impact of p16INK4a (p16) expression on clinical efficacy of induction low-dose fract... | DisGeNET | Detail |
Human papillomavirus (HPV), p16 expression, and TP53 mutations are known prognostic factors in head ... | DisGeNET | Detail |
Among those HNSCCs that were positive for HR-HPV, 18 (100%) of 18 originated from the oropharynx, wh... | DisGeNET | Detail |
These results suggest that UGT2B17-deletion interacting with p16 (+) may modify effects of smoking o... | DisGeNET | Detail |
Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, CDKN2A (encoding the p16 protein) is silenced nearly exclusively in the advanced areas of t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These accumulations were associated with decreased levels of Cyclin A1, B1, and E1, and increased ex... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferativ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cdkn2a loss is associated with mTORC2 and Akt activation in human and murine melanocytic neoplasms. | DisGeNET | Detail |
Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells o... | DisGeNET | Detail |
HPV DNA genotyping and methylation of gene p16 INK4A in cervical LSIL. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In specific PC populations, including in Italy, hereditary cancer predisposition genes such as CDKN2... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Copy number and loss of heterogeneity (LOH) profiles were similar in all six carcinomas; however, th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Loss of the CDK4/6 inhibitor CDKN2A is a signature genetic event in PDA. | DisGeNET | Detail |
Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Deletions of RDINK4/ARF enhancer in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In total, 24% of the HNSCCUP patients were p16 positive. p16 overexpression in neck metastasis was p... | DisGeNET | Detail |
Germline CDKN2A mutations affecting p16(INK4a) were detected in 8 unrelated probands (13.6 %), inclu... | DisGeNET | Detail |
By contrast, p16 negatively, but not HPV 16 genotype, is an independent adverse prognosticator after... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Germline mutations in the tumour suppressor gene CDKN2A occur in 5-20% of familial melanoma cases. | DisGeNET | Detail |
Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma. | DisGeNET | Detail |
Genetics of familial melanoma: 20 years after CDKN2A. | DisGeNET | Detail |
Familial melanomas with CDKN2A mutations preferentially express a histologic phenotype of dense pigm... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A borderline between cholangiolocellular carcinoma and the surrounding ductular reaction was clearly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results show that the clinical candidate AKT inhibitor MK-2206 promotes ARF nucleolar localizati... | DisGeNET | Detail |
Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorab... | DisGeNET | Detail |
Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis i... | DisGeNET | Detail |
An adenoviral construct of the human p14ARF gene (a tumor suppressor) and a 22 amino acid sequence o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ECCCs had SCA-like features with rare expression of estrogen receptor/progesterone receptor (18.8%/6... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Biallelic inactivation of CDKN2A emerged exclusively in invasive melanomas. | DisGeNET | Detail |
Polysomy 6 and p16 deletion were significantly more frequent in noninvasive than in non-neoplastic s... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Progression to a clinically aggressive meningioma is linked to inactivation of CDKN2A/B genes, and a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using this approach, numerous studies have associated SNPs on chromosome 9p21.3 situated near the cy... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Deletions of EBF1, IKZF1, and CDKN2A/B have an independent adverse prognosis for adolescents and adu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To determine the potential association between HPV infection and the squamous cell component of urot... | DisGeNET | Detail |
Furthermore, p16 overexpression in eyelid SCs was also significantly higher than that in other eyeli... | DisGeNET | Detail |
Role of P14 and MGMT gene methylation in hepatocellular carcinomas: a meta-analysis. | DisGeNET | Detail |
Sirtuin 6 in turn abrogated the inducing effect of TGF-β1/H2O2/HOCl on cellular senescence of HCC ce... | DisGeNET | Detail |
During the last 10 years, there has been a clear delineation of the landscape of genetic alterations... | DisGeNET | Detail |
The p16-Leiden founder mutation in the CDKN2A gene is the most common cause of Familial Atypical Mul... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The majority of North American respondents in this survey systematically test for HPV-DNA and/or p16... | DisGeNET | Detail |
Interestingly, the prognostic significance of p16 overexpression is different from that reported in ... | DisGeNET | Detail |
Among these biomarkers, p53 is the strongest prognostic marker in OPC and p53 in addition to p16 sup... | DisGeNET | Detail |
Significant correlations were confirmed between p16 positivity and oropharyngeal cancer, MMP1 and p1... | DisGeNET | Detail |
Overall, this study provides evidence of epigenetic changes to the downstream region of the CDKN2A l... | DisGeNET | Detail |
Prognostic value of p16 expression irrespective of human papillomavirus status in patients with orop... | DisGeNET | Detail |
Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland. | DisGeNET | Detail |
NA | DisGeNET | Detail |
The results showed that the membrane weighted index of β-catenin was inversely correlated with p16 p... | DisGeNET | Detail |
Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genomic aberrations affecting the genes encoding factor H (FH) and the five FH-related proteins (FHR... | DisGeNET | Detail |
We here evaluated p16 INK4A as a prognostic marker of treatment response and survival in our SCCHN p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Diffuse p16 expression was associated with younger age at presentation (P<0.0001), basaloid and wart... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunohistochemistry (IHC) was used to examine STMN1 and p16 expression in fallopian tube specimens ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Different roles for p16(INK) (4a) -Rb pathway and INK4a/ARF methylation between adenocarcinomas of g... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
An increased CDKN2A gene expression in carotid plaques may increase the severity of ICA stenosis, th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Herein we showed that activation of CD47 in human astrocytoma cell lines U87 and CCF- STTG1 (Grade I... | DisGeNET | Detail |
CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
An increased CDKN2A gene expression in carotid plaques may increase the severity of ICA stenosis, th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Barrett's esophagus is thought to progress to esophageal adenocarcinoma (EAC) through a stepwise pro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cance... | DisGeNET | Detail |
Transfection of the DNAzyme caused significant down-regulation of DNMT1 expression and reactivation ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, cases of ambiguous p16(INK4a) overexpression are regularly detected in the head and neck: p... | DisGeNET | Detail |
In a cross-sectional study of 138 women with no history of breast cancer who underwent reduction mam... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Quantitative analysis of CDKN2A methylation, mRNA, and p16(INK4a) protein expression in children and... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-ris... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Vitamin C protects against UV irradiation-induced apoptosis through reactivating silenced tumor supp... | DisGeNET | Detail |
CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p1... | DisGeNET | Detail |
Methylation of APC and/or p16 was related to advanced staging in non-small cell lung cancer (NSCLC) ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386505388 dbSNP
- Genome
- hg19
- Position
- chr9:21,967,751-21,995,300
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- MUTATION
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/2704
- Variant (CIViC) (CIViC Variant)
- LOSS-OF-FUNCTION
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/2708
Genome browser